Registro:

Referencias:

• Gomez Ravetti, M., Moscato, P., Identification of a 5-Protein Biomarker Molecular Signature for Predicting Alzheimer's Disease (2008) PLoS One, 3, pp. e3111
• Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins (2007) Nat Med, 13, pp. 1359-1362
• Blalock, E.M., Geddes, J.W., Chen, K.C., Porter, N.M., Markesbery, W.R., Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses (2004) Proceedings of the National Academy of Sciences of the United States of America, 101, pp. 2173-2178
• Schmitt, F.A., Davis, D.G., Wekstein, D.R., Smith, C.D., Ashford, J.W., "Preclinical" AD revisited: Neuropathology of cognitively normal older adults (2000) Neurology, 55, pp. 370-376
• Haroutunian, V., Purohit, D.P., Perl, D.P., Marin, D., Khan, K., Neurofibrillary Tangles in Nondemented Elderly Subjects and Mild Alzheimer Disease (1999) Arch Neurol, 56, pp. 713-718
• Price, D.L., Sisodia, S.S., Mutant genes in familial Alzheimer's disease and transgenic models (1998) Annual Review of Neuroscience, 21, pp. 479-505
• Price, J.L., The relationship between tangle and plaque formation during healthy aging and mild dementia (1993) Neurobiology of Aging, 14, pp. 661-663
• Price, J.L., Davis, P.B., Morris, J.C., White, D.L., The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease (1991) Neurobiology of Aging, 12, pp. 295-312
• Robbins, K., Sandeep, J., Zhang, W., Rekaya, R., Classification of incipient Alzheimer patients using gene expression data: Dealing with potential misdiagnosis (2006) Online Journal of Bioinformatics, 7, p. 9
• Sandeep, J., Robbins, K., Zhang, W., Rekaya, R., Effects of Misdiagnosis in Input Data on the Identification of Differential Expression Genes in Incipient Alzheimer Patients (2008) In Silico Biology, 8, p. 9
• Grosse, I., Bernaola-Galvan, P., Carpena, P., Roman-Roldan, R., Oliver, J., Analysis of symbolic sequences using the Jensen-Shannon divergence (2002) Phys Rev E Stat Nonlin Soft Matter Phys, 65, p. 041905
• Moscato, P., Mendes, A., Berretta, R., Benchmarking a memetic algorithm for ordering microarray data (2007) Biosystems, 88, pp. 56-75
• Berretta, R., Costa, W., Moscato, P., (2008) Combinatorial Optimization Models for Finding Genetic Signatures from Gene Expression Datasets, pp. 363-377. , In: Keith JM, ed. Bioinformatics Humana Press
• Gubern, C., Hurtado, O., Rodriguez, R., Morales, J.R., Romera, V.G., Validation of housekeeping genes for quantitative real-time PCR in in-vivo and in-vitro models of cerebral ischaemia (2009) BMC Mol Biol, 10, p. 57
• Santos, A.R., Duarte, C.B., Validation of internal control genes for expression studies: Effects of the neurotrophin BDNF on hippocampal neurons (2008) J Neurosci Res, 86, pp. 3684-3692
• Johansson, S., Fuchs, A., Okvist, A., Karimi, M., Harper, C., Validation of endogenous controls for quantitative gene expression analysis: Application on brain cortices of human chronic alcoholics (2007) Brain Res, 1132, pp. 20-28
• Hughes, V., Smith, S., Garcia-Sanchez, A., Sales, J., Stevenson, K., Proteomic comparison of Mycobacterium avium subspecies paratuberculosis grown in vitro and isolated from clinical cases of ovine paratuberculosis (2007) Microbiology, 153, pp. 196-205
• Preece, P., Cairns, N.J., Quantifying mRNA in postmortem human brain: Influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance (2003) Brain Res Mol Brain Res, 118, pp. 60-71
• Chang, J.T., Nevins, J.R., GATHER: A systems approach to interpreting genomic signatures (2006) Bioinformatics, 22, pp. 2926-2933
• Ariadne Genomics, I., (2007) Pathway Studio™, , 5.0 ed
• Ongwijitwat, S., Wong-Riley, M.T., Functional analysis of the rat cytochrome c oxidase subunit 6A1 promoter in primary neurons (2004) Gene, 337, pp. 163-171
• Wong-Riley, M., Guo, A., Bachman, N.J., Lomax, M.I., Human COX6A1 gene: Promoter analysis, cDNA isolation and expression in the monkey brain (2000) Gene, 247, pp. 63-75
• Ben-Shachar, D., Karry, R., Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression (2008) PLoS One, 3, pp. e3676
• Ji, B., La, Y., Gao, L., Zhu, H., Tian, N., A Comparative Proteomics Analysis of Rat Mitochondria from the Cerebral Cortex and Hippocampus in Response to Antipsychotic Medications (2009) J Proteome Res, 8, pp. 3633-3641
• Zhang, J., Li, X., Wang, Y., Ji, J., Yang, F., Association study on the mitochondrial gene NDUFV2 and bipolar disorder in the Chinese Han population (2009) J Neural Transm, 116, pp. 357-361
• Washizuka, S., Iwamoto, K., Kakiuchi, C., Bundo, M., Kato, T., Expression of mitochondrial complex I subunit gene NDUFV2 in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia (2009) Neurosci Res, 63, pp. 199-204
• Xu, C., Li, P.P., Kennedy, J.L., Green, M., Hughes, B., Further support for association of the mitochondrial complex I subunit gene NDUFV2 with bipolar disorder (2008) Bipolar Disord, 10, pp. 105-110
• Ben-Shachar, D., Karry, R., Sp1 expression is disrupted in schizophrenia; a possible mechanism for the abnormal expression of mitochondrial complex I genes, NDUFV1 and NDUFV2 (2007) PLoS One, 2, pp. e817
• Lazarou, M., McKenzie, M., Ohtake, A., Thorburn, D.R., Ryan, M.T., Analysis of the assembly profiles for mitochondrial- and nuclear-DNA-encoded subunits into complex I (2007) Mol Cell Biol, 27, pp. 4228-4237
• Nakatani, N., Hattori, E., Ohnishi, T., Dean, B., Iwayama, Y., Genomewide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: Relevance to neuronal network perturbation (2006) Hum Mol Genet, 15, pp. 1949-1962
• Spires, T.L., Molnar, Z., Kind, P.C., Cordery, P.M., Upton, A.L., Activitydependent regulation of synapse and dendritic spine morphology in developing barrel cortex requires phospholipase C-beta1 signalling (2005) Cereb Cortex, 15, pp. 385-393
• Litosch, I., Novel mechanisms for feedback regulation of phospholipase Cbeta activity (2002) IUBMB Life, 54, pp. 253-260
• Bohm, D., Schwegler, H., Kotthaus, L., Nayernia, K., Rickmann, M., Disruption of PLC-beta 1-mediated signal transduction in mutant mice causes age-dependent hippocampal mossy fiber sprouting and neurodegeneration (2002) Mol Cell Neurosci, 21, pp. 584-601
• Hannan, A.J., Blakemore, C., Katsnelson, A., Vitalis, T., Huber, K.M., PLC-beta1, activated via mGluRs, mediates activity-dependent differentiation in cerebral cortex (2001) Nat Neurosci, 4, pp. 282-288
• Tiveci, S., Akin, A., Cakir, T., Saybasili, H., Ulgen, K., Modelling of calcium dynamics in brain energy metabolism and Alzheimer's disease (2005) Comput Biol Chem, 29, pp. 151-162
• Moreira, P.I., Santos, M.S., Seica, R., Oliveira, C.R., Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes (2007) J Neurol Sci, 257, pp. 206-214
• Laughton, J.D., Bittar, P., Charnay, Y., Pellerin, L., Kovari, E., Metabolic compartmentalization in the human cortex and hippocampus: Evidence for a cell- and region-specific localization of lactate dehydrogenase 5 and pyruvate dehydrogenase (2007) BMC Neurosci, 8, p. 35
• Landfield, P.W., Blalock, E.M., Chen, K.C., Porter, N.M., A new glucocorticoid hypothesis of brain aging: Implications for Alzheimer's disease (2007) Curr Alzheimer Res, 4, pp. 205-212
• Elgh, E., Lindqvist Astot, A., Fagerlund, M., Eriksson, S., Olsson, T., Cognitive dysfunction, hippocampal atrophy and glucocorticoid feedback in Alzheimer's disease (2006) Biol Psychiatry, 59, pp. 155-161
• Bao, A.M., Meynen, G., Swaab, D.F., The stress system in depression and neurodegeneration: Focus on the human hypothalamus (2008) Brain Res Rev, 57, pp. 531-553
• Lee, H.K., Kumar, P., Fu, Q., Rosen, K.M., Querfurth, H.W., The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid (2009) Mol Biol Cell, 20, pp. 1533-1544
• Escribano, L., Simon, A.M., Perez-Mediavilla, A., Salazar-Colocho, P., Del Rio, J., Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer's disease mouse model (2009) Biochem Biophys Res Commun, 379, pp. 406-410
• Bonomo, S.M., Rigamonti, A.E., Giunta, M., Galimberti, D., Guaita, A., Menopausal transition: A possible risk factor for brain pathologic events (2009) Neurobiol Aging, 30, pp. 71-80
• Aisa, B., Gil-Bea, F.J., Marcos, B., Tordera, R., Lasheras, B., Neonatal stress affects vulnerability of cholinergic neurons and cognition in the rat: Involvement of the HPA axis (2009) Psychoneuroendocrinology
• Sotiropoulos, I., Cerqueira, J.J., Catania, C., Takashima, A., Sousa, N., Stress and glucocorticoid footprints in the brain-the path from depression to Alzheimer's disease (2008) Neurosci Biobehav Rev, 32, pp. 1161-1173
• Jing, H., Iwasaki, Y., Nishiyama, M., Taguchi, T., Tsugita, M., Multisignal regulation of the rat NMDA1 receptor subunit gene-a pivotal role of glucocorticoid-dependent transcription (2008) Life Sci, 82, pp. 1137-1141
• White, L.D., Cory-Slechta, D.A., Gilbert, M.E., Tiffany-Castiglioni, E., Zawia, N.H., New and evolving concepts in the neurotoxicology of lead (2007) Toxicol Appl Pharmacol, 225, pp. 1-27
• Green, K.N., Billings, L.M., Roozendaal, B., McGaugh, J.L., LaFerla, F.M., Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease (2006) J Neurosci, 26, pp. 9047-9056
• de Quervain, D.J., Poirier, R., Wollmer, M.A., Grimaldi, L.M., Tsolaki, M., Glucocorticoid-related genetic susceptibility for Alzheimer's disease (2004) Hum Mol Genet, 13, pp. 47-52
• Dai, J., Buijs, R., Swaab, D., Glucocorticoid hormone (cortisol) affects axonal transport in human cortex neurons but shows resistance in Alzheimer's disease (2004) Br J Pharmacol, 143, pp. 606-610
• Polleri, A., Gianelli, M.V., Murialdo, G., Dementia: A neuroendocrine perspective (2002) J Endocrinol Invest, 25, pp. 73-83
• Chen, H., Sun, S., Mei, Y., Liu, C., Liu, A., The effect of beta-amyloid on neurons and the influence of glucocorticoid and age on such effect (2002) J Huazhong Univ Sci Technolog Med Sci, 22, pp. 250-252
• Aisen, P.S., The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease (2002) Lancet Neurol, 1, pp. 279-284
• Rasmuson, S., Andrew, R., Nasman, B., Seckl, J.R., Walker, B.R., Increased glucocorticoid production and altered cortisol metabolism in women with mild to moderate Alzheimer's disease (2001) Biol Psychiatry, 49, pp. 547-552
• Pedersen, W.A., McCullers, D., Culmsee, C., Haughey, N.J., Herman, J.P., Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease (2001) Neurobiol Dis, 8, pp. 492-503
• Dubois, M., Lalonde, R., Julien, J.P., Strazielle, C., Mice with the deleted neurofilament of low-molecular-weight (Nefl) gene: 1. Effects on regional brain metabolism (2005) J Neurosci Res, 80, pp. 741-750
• Jordanova, A., De Jonghe, P., Boerkoel, C.F., Takashima, H., De Vriendt, E., Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease (2003) Brain, 126, pp. 590-597
• Abe, A., Numakura, C., Saito, K., Koide, H., Oka, N., Neurofilament light chain polypeptide gene mutations in Charcot-Marie-Tooth disease: Nonsense mutation probably causes a recessive phenotype (2009) J Hum Genet, 54, pp. 94-97
• Tradewell, M.L., Durham, H.D., Mushynski, W.E., Gentil, B.J., Mitochondrial and axonal abnormalities precede disruption of the neurofilament network in a model of charcot-marie-tooth disease type 2E and are prevented by heat shock proteins in a mutant-specific fashion (2009) J Neuropathol Exp Neurol, 68, pp. 642-652
• Evgrafov, O.V., Mersiyanova, I., Irobi, J., Van Den Bosch, L., Dierick, I., Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy (2004) Nat Genet, 36, pp. 602-606
• Nakagawa, M., Takashima, H., Update on hereditary neuropathy (2004) Rinsho Shinkeigaku, 44, pp. 991-994
• Takashima, H., Molecular genetics of inherited neuropathies (2006) Rinsho Shinkeigaku, 46, pp. 1-18
• Lus, G., Nelis, E., Jordanova, A., Lofgren, A., Cavallaro, T., Charcot- Marie-Tooth disease with giant axons: A clinicopathological and genetic entity (2003) Neurology, 61, pp. 988-990
• Saba, R., Goodman, C.D., Huzarewich, R.L., Robertson, C., Booth, S.A., A miRNA signature of prion induced neurodegeneration (2008) PLoS One, 3, pp. e3652
• Sorensen, G., Medina, S., Parchaliuk, D., Phillipson, C., Robertson, C., Comprehensive transcriptional profiling of prion infection in mouse models reveals networks of responsive genes (2008) BMC Genomics, 9, p. 114
• Heese, K., Nagai, Y., Sawada, T., Identification of a new synaptic vesicle protein 2B mRNA transcript which is up-regulated in neurons by amyloid beta peptide fragment (1-42) (2001) Biochem Biophys Res Commun, 289, pp. 924-928
• Heese, K., Nagai, Y., Sawada, T., The 39 untranslated region of the new rat synaptic vesicle protein 2B mRNA transcript inhibits translational efficiency (2002) Brain Res Mol Brain Res, 104, pp. 127-131
• Morgans, C.W., Kensel-Hammes, P., Hurley, J.B., Burton, K., Idzerda, R., Loss of the Synaptic Vesicle Protein SV2B results in reduced neurotransmission and altered synaptic vesicle protein expression in the retina (2009) PLoS One, 4, pp. e5230
• Lazzell, D.R., Belizaire, R., Thakur, P., Sherry, D.M., Janz, R., SV2B regulates synaptotagmin 1 by direct interaction (2004) J Biol Chem, 279, pp. 52124-52131
• Veinbergs, I., Mante, M., Jung, M.W., Van Uden, E., Masliah, E., Synaptotagmin and synaptic transmission alterations in apolipoprotein Edeficient mice (1999) Prog Neuropsychopharmacol Biol Psychiatry, 23, pp. 519-531
• Davidsson, P., Blennow, K., Neurochemical dissection of synaptic pathology in Alzheimer's disease (1998) Int Psychogeriatr, 10, pp. 11-23
• Ferrer, I., Marti, E., Tortosa, A., Blasi, J., Dystrophic neurites of senile plaques are defective in proteins involved in exocytosis and neurotransmission (1998) J Neuropathol Exp Neurol, 57, pp. 218-225
• Shimohama, S., Kamiya, S., Taniguchi, T., Akagawa, K., Kimura, J., Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease (1997) Biochem Biophys Res Commun, 236, pp. 239-242
• Davidsson, P., Jahn, R., Bergquist, J., Ekman, R., Blennow, K., Synaptotagmin, a synaptic vesicle protein, is present in human cerebrospinal fluid: A new biochemical marker for synaptic pathology in Alzheimer disease? (1996) Mol Chem Neuropathol, 27, pp. 195-210
• Reddy, P.H., Mani, G., Park, B.S., Jacques, J., Murdoch, G., Differential loss of synaptic proteins in Alzheimer's disease: Implications for synaptic dysfunction (2005) J Alzheimers Dis, 7, pp. 103-117. , discussion 173-180
• Kirikoshi, H., Katoh, M., Expression of WNT7A in human normal tissues and cancer, and regulation of WNT7A and WNT7B in human cancer (2002) Int J Oncol, 21, pp. 895-900
• Wang, Y., Liu, S., Zhu, H., Zhang, W., Zhang, G., FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma (2008) Int J Cancer, 123, pp. 561-568
• Hongisto, V., Vainio, J.C., Thompson, R., Courtney, M.J., Coffey, E.T., The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivationinduced neuronal death (2008) Mol Cell Biol, 28, pp. 1515-1527
• Hagen, T., Cross, D.A., Culbert, A.A., West, A., Frame, S., FRAT1, a substrate-specific regulator of glycogen synthase kinase-3 activity, is a cellular substrate of protein kinase A (2006) J Biol Chem, 281, pp. 35021-35029
• Hongisto, V., Smeds, N., Brecht, S., Herdegen, T., Courtney, M.J., Lithium blocks the c-Jun stress response and protects neurons via its action on glycogen synthase kinase 3 (2003) Mol Cell Biol, 23, pp. 6027-6036
• Hino, S., Michiue, T., Asashima, M., Kikuchi, A., Casein kinase I epsilon enhances the binding of Dvl-1 to Frat-1 and is essential for Wnt-3a-induced accumulation of beta-catenin (2003) J Biol Chem, 278, pp. 14066-14073
• Hay, E., Faucheu, C., Suc-Royer, I., Touitou, R., Stiot, V., Interaction between LRP5 and Frat1 mediates the activation of the Wnt canonical pathway (2005) J Biol Chem, 280, pp. 13616-13623
• Fraser, E., Young, N., Dajani, R., Franca-Koh, J., Ryves, J., Identification of the Axin and Frat binding region of glycogen synthase kinase-3 (2002) J Biol Chem, 277, pp. 2176-2185
• Franca-Koh, J., Yeo, M., Fraser, E., Young, N., Dale, T.C., The regulation of glycogen synthase kinase-3 nuclear export by Frat/GBP (2002) J Biol Chem, 277, pp. 43844-43848
• Saitoh, T., Moriwaki, J., Koike, J., Takagi, A., Miwa, T., Molecular cloning and characterization of FRAT2, encoding a positive regulator of the WNT signaling pathway (2001) Biochem Biophys Res Commun, 281, pp. 815-820
• Killick, R., Pollard, C.C., Asuni, A.A., Mudher, A.K., Richardson, J.C., Presenilin 1 independently regulates beta-catenin stability and transcriptional activity (2001) J Biol Chem, 276, pp. 48554-48561
• Culbert, A.A., Brown, M.J., Frame, S., Hagen, T., Cross, D.A., GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity (2001) FEBS Lett, 507, pp. 288-294
• Crowder, R.J., Freeman, R.S., Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal (2000) J Biol Chem, 275, pp. 34266-34271
• Katoh, M., Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis (2007) Stem Cell Rev, 3, pp. 30-38
• Liu, C., Wang, Y., Smallwood, P.M., Nathans, J., An essential role for Frizzled5 in neuronal survival in the parafascicular nucleus of the thalamus (2008) J Neurosci, 28, pp. 5641-5653
• Carmon, K.S., Loose, D.S., Wnt7a interaction with Fzd5 and detection of signaling activation using a split eGFP (2008) Biochem Biophys Res Commun, 368, pp. 285-291
• Steventon, B., Araya, C., Linker, C., Kuriyama, S., Mayor, R., Differential requirements of BMP and Wnt signalling during gastrulation and neurulation define two steps in neural crest induction (2009) Development, 136, pp. 771-779
• Lee, M.Y., Lim, H.W., Lee, S.H., Han, H.J., Smad, PI3K/Akt, and Wnt-Dependent Signaling Pathways are Involved in BMP-4-Induced ES Cell Self-Renewal (2009) Stem Cells
• Kelberman, D., de Castro, S.C., Huang, S., Crolla, J.A., Palmer, R., SOX2 plays a critical role in the pituitary, forebrain, and eye during human embryonic development (2008) J Clin Endocrinol Metab, 93, pp. 1865-1873
• Shi, Y., Sun, G., Zhao, C., Stewart, R., Neural stem cell self-renewal (2008) Crit Rev Oncol Hematol, 65, pp. 43-53
• Linker, C., Stern, C.D., Neural induction requires BMP inhibition only as a late step, and involves signals other than FGF and Wnt antagonists (2004) Development, 131, pp. 5671-5681
• Tam, W.L., Lim, C.Y., Han, J., Zhang, J., Ang, Y.S., T-cell factor 3 regulates embryonic stem cell pluripotency and self-renewal by the transcriptional control of multiple lineage pathways (2008) Stem Cells, 26, pp. 2019-2031
• Ruzov, A., Hackett, J.A., Prokhortchouk, A., Reddington, J.P., Madej, M.J., The interaction of xKaiso with xTcf3: A revised model for integration of epigenetic and Wnt signalling pathways (2009) Development, 136, pp. 723-727
• Fancy, S.P., Baranzini, S.E., Zhao, C., Yuk, D.I., Irvine, K.A., Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS (2009) Genes Dev, 23, pp. 1571-1585
• Koslowski, M.J., Kubler, I., Chamaillard, M., Schaeffeler, E., Reinisch, W., Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease (2009) PLoS ONE, 4, pp. e4496
• Schinner, S., Wnt-signalling and the metabolic syndrome (2009) Horm Metab Res, 41, pp. 159-163
• Nazwar, T.A., Glassmann, A., Schilling, K., Expression and molecular diversity of Tcf7l2 in the developing murine cerebellum and brain (2009) J Neurosci Res, 87, pp. 1532-1546
• Ye, F., Chen, Y., Hoang, T., Montgomery, R.L., Zhao, X.H., HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the betacatenin- TCF interaction (2009) Nat Neurosci, 12, pp. 829-838
• Murray, K.D., Rubin, C.M., Jones, E.G., Chalupa, L.M., Molecular correlates of laminar differences in the macaque dorsal lateral geniculate nucleus (2008) J Neurosci, 28, pp. 12010-12022
• Murray, K.D., Choudary, P.V., Jones, E.G., Nucleus- and cell-specific gene expression in monkey thalamus (2007) Proc Natl Acad Sci U S A, 104, pp. 1989-1994
• Lukas, J., Mazna, P., Valenta, T., Doubravska, L., Pospichalova, V., Dazap2 modulates transcription driven by the Wnt effector TCF-4 (2009) Nucleic Acids Res, 37, pp. 3007-3020
• Lepourcelet, M., Shivdasani, R.A., Characterization of a novel mammalian Groucho isoform and its role in transcriptional regulation (2002) J Biol Chem, 277, pp. 47732-47740
• Bachar-Dahan, L., Goltzmann, J., Yaniv, A., Gazit, A., Engrailed-1 negatively regulates beta-catenin transcriptional activity by destabilizing beta-catenin via a glycogen synthase kinase-3beta-independent pathway (2006) Mol Biol Cell, 17, pp. 2572-2580
• Daniels, D.L., Weis, W.I., Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation (2005) Nat Struct Mol Biol, 12, pp. 364-371
• Bauer, J., Plaschke, K., Martin, E., Bardenheuer, H.J., Hoyer, S., Causes and consequences of neuronal energy deficit in sporadic Alzheimer's disease (1997) Ann N Y Acad Sci, 826, pp. 379-381
• Lu, Y., He, X., Zhong, S., Cross-species microarray analysis with the OSCAR system suggests an INSRRPax6RNQO1 neuro-protective pathway in aging and Alzheimer's disease (2007) Nucleic Acids Res, 35, pp. W105-W114
• Wang, H., Wang, R., Zhao, Z., Ji, Z., Xu, S., Coexistences of insulin signaling-related proteins and choline acetyltransferase in neurons (2009) Brain Res, 1249, pp. 237-243
• Frolich, L., Blum-Degen, D., Riederer, P., Hoyer, S., A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease (1999) Ann N Y Acad Sci, 893, pp. 290-293
• Hoyer, S., Age as risk factor for sporadic dementia of the Alzheimer type? (1994) Ann N Y Acad Sci, 719, pp. 248-256
• Hoyer, S., Lannert, H., Inhibition of the neuronal insulin receptor causes Alzheimer-like disturbances in oxidative/energy brain metabolism and in behavior in adult rats (1999) Ann N Y Acad Sci, 893, pp. 301-303
• Hoyer, S., Lee, S.K., Loffler, T., Schliebs, R., Inhibition of the neuronal insulin receptor (2000) An in vivo model for sporadic Alzheimer disease? Ann N Y Acad Sci, 920, pp. 256-258
• Hoyer, S., Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease (1996) Acta Neurol Scand Suppl, 165, pp. 18-24
• Verkhratsky, A., Toescu, E.C., Endoplasmic reticulum Ca(2+) homeostasis and neuronal death (2003) J Cell Mol Med, 7, pp. 351-361
• Norris, C.M., Kadish, I., Blalock, E.M., Chen, K.C., Thibault, V., Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models (2005) J Neurosci, 25, pp. 4649-4658
• Bojarski, L., Herms, J., Kuznicki, J., Calcium dysregulation in Alzheimer's disease (2008) Neurochem Int, 52, pp. 621-633
• Cowburn, R.F., Popescu, B.O., Ankarcrona, M., Dehvari, N., Cedazo-Minguez, A., Presenilin-mediated signal transduction (2007) Physiol Behav, 92, pp. 93-97
• Giacomello, M., Barbiero, L., Zatti, G., Squitti, R., Binetti, G., Reduction of Ca2+ stores and capacitative Ca2+ entry is associated with the familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia (2005) Neurobiol Dis, 18, pp. 638-648
• Peers, C., Smith, I.F., Boyle, J.P., Pearson, H.A., Remodelling of Ca2+ homeostasis in type I cortical astrocytes by hypoxia: Evidence for association with Alzheimer's disease (2004) Biol Chem, 385, pp. 285-289
• LaFerla, F.M., Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease (2002) Nat Rev Neurosci, 3, pp. 862-872
• Eckert, A., Forstl, H., Zerfass, R., Hennerici, M., Muller, W.E., Free intracellular calcium in peripheral cells in Alzheimer's disease (1997) Neurobiol Aging, 18, pp. 281-284
• Schubert, P., Ogata, T., Miyazaki, H., Marchini, C., Ferroni, S., Pathological immuno-reactions of glial cells in Alzheimer's disease and possible sites of interference (1998) J Neural Transm Suppl, 54, pp. 167-174
• Eckert, A., Forstl, H., Zerfass, R., Hartmann, H., Muller, W.E., Lymphocytes and neutrophils as peripheral models to study the effect of beta-amyloid on cellular calcium signalling in Alzheimer's disease (1996) Life Sci, 59, pp. 499-510
• Salkovic-Petrisic, M., Hoyer, S., Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: An experimental approach (2007) J Neural Transm, (SUPPL.), pp. 217-233
• Qin, W., Zhao, W., Ho, L., Wang, J., Walsh, K., Regulation of forkhead transcription factor FoxO3a contributes to calorie restriction-induced prevention of Alzheimer's disease-type amyloid neuropathology and spatial memory deterioration (2008) Ann N Y Acad Sci, 1147, pp. 335-347
• Carro, E., Trejo, J.L., Spuch, C., Bohl, D., Heard, J.M., Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: New cues into the human disease? (2006) Neurobiol Aging, 27, pp. 1618-1631
• Rhein, V., Eckert, A., Effects of Alzheimer's amyloid-beta and tau protein on mitochondrial function - role of glucose metabolism and insulin signalling (2007) Arch Physiol Biochem, 113, pp. 131-141
• Abbas, T., Faivre, E., Holscher, C., Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease (2009) Behav Brain Res
• Castri, P., Iacovelli, L., De Blasi, A., Giubilei, F., Moretti, A., Reduced insulin-induced phosphatidylinositol-3-kinase activation in peripheral blood mononuclear leucocytes from patients with Alzheimer's disease (2007) Eur J Neurosci, 26, pp. 2469-2472
• Li, L., Holscher, C., Common pathological processes in Alzheimer disease and type 2 diabetes: A review (2007) Brain Res Rev, 56, pp. 384-402
• Salkovic-Petrisic, M., Tribl, F., Schmidt, M., Hoyer, S., Riederer, P., Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway (2006) J Neurochem, 96, pp. 1005-1015
• Biessels, G.J., Kappelle, L.J., Increased risk of Alzheimer's disease in Type II diabetes: Insulin resistance of the brain or insulin-induced amyloid pathology? (2005) Biochem Soc Trans, 33, pp. 1041-1044
• Nelson, T.J., Alkon, D.L., Insulin and cholesterol pathways in neuronal function, memory and neurodegeneration (2005) Biochem Soc Trans, 33, pp. 1033-1036
• Biessels, G.J., Bravenboer, B., Gispen, W.H., Glucose, insulin and the brain: Modulation of cognition and synaptic plasticity in health and disease: A preface (2004) Eur J Pharmacol, 490, pp. 1-4
• Morgan, C., Colombres, M., Nunez, M.T., Inestrosa, N.C., Structure and function of amyloid in Alzheimer's disease (2004) Prog Neurobiol, 74, pp. 323-349
• Zhao, W.Q., Townsend, M., Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease (2009) Biochim Biophys Acta, 1792, pp. 482-496
• De Felice, F.G., Vieira, M.N., Bomfim, T.R., Decker, H., Velasco, P.T., Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Abeta oligomers (2009) Proc Natl Acad Sci U S A, 106, pp. 1971-1976
• Chen, Y., Zhou, K., Wang, R., Liu, Y., Kwak, Y.D., Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription (2009) Proc Natl Acad Sci U S A, 106, pp. 3907-3912
• Puglielli, L., Aging of the brain, neurotrophin signaling, and Alzheimer's disease: Is IGF1-R the common culprit? (2008) Neurobiol Aging, 29, pp. 795-811
• Jolivalt, C.G., Lee, C.A., Beiswenger, K.K., Smith, J.L., Orlov, M., Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: Parallels with Alzheimer's disease and correction by insulin (2008) J Neurosci Res, 86, pp. 3265-3274
• de Tullio, M.B., Morelli, L., Castano, E.M., The irreversible binding of amyloid peptide substrates to insulin-degrading enzyme: A biological perspective (2008) Prion, 2, pp. 51-56
• Dore, S., Kar, S., Quirion, R., Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylininduced toxicity (1997) Proc Natl Acad Sci U S A, 94, pp. 4772-4777
• Gandy, S., Czernik, A.J., Greengard, P., Phosphorylation of Alzheimer disease amyloid precursor peptide by protein kinase C and Ca2+/calmodulindependent protein kinase II (1988) Proc Natl Acad Sci U S A, 85, pp. 6218-6221
• Deutsch, S.I., Rosse, R.B., Lakshman, R.M., Dysregulation of tau phosphorylation is a hypothesized point of convergence in the pathogenesis of alzheimer's disease, frontotemporal dementia and schizophrenia with therapeutic implications (2006) Prog Neuropsychopharmacol Biol Psychiatry, 30, pp. 1369-1380
• Wickelgren, I., Tracking insulin to the mind (1998) Science, 280, pp. 517-519
• Jafferali, S., Dumont, Y., Sotty, F., Robitaille, Y., Quirion, R., Insulinlike growth factor-I and its receptor in the frontal cortex, hippocampus, and cerebellum of normal human and alzheimer disease brains (2000) Synapse, 38, pp. 450-459
• Brune, S., Kolsch, H., Ptok, U., Majores, M., Schulz, A., Polymorphism in the peroxisome proliferator-activated receptor alpha gene influences the risk for Alzheimer's disease (2003) J Neural Transm, 110, pp. 1041-1050
• Frolich, L., Blum-Degen, D., Bernstein, H.G., Engelsberger, S., Humrich, J., Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease (1998) J Neural Transm, 105, pp. 423-438
• Grunblatt, E., Hoyer, S., Riederer, P., Gene expression profile in streptozotocin rat model for sporadic Alzheimer's disease (2004) J Neural Transm, 111, pp. 367-386
• Hoyer, S., Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis (1998) J Neural Transm, 105, pp. 415-422
• Hoyer, S., The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review (2002) J Neural Transm, 109, pp. 991-1002
• Hoyer, S., The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: An update (2002) J Neural Transm, 109, pp. 341-360
• Hoyer, S., Nitsch, R., Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type (1989) J Neural Transm, 75, pp. 227-232
• Xu, W.H., Huber, R., Riepe, M.W., Gender- and region-specific expression of insulin receptor protein in mouse brain: Effect of mild inhibition of oxidative phosphorylation (2007) J Neural Transm, 114, pp. 373-377
• Hoyer, S., Nitsch, R., Oesterreich, K., Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: A crosssectional comparison against advanced late-onset and incipient early-onset cases (1991) J Neural Transm Park Dis Dement Sect, 3, pp. 1-14
• Blum-Degen, D., Frolich, L., Hoyer, S., Riederer, P., Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders? (1995) J Neural Transm Suppl, 46, pp. 139-147
• Hoyer, S., Models of Alzheimer's disease: Cellular and molecular aspects (1997) J Neural Transm Suppl, 49, pp. 11-21
• Hoyer, S., Muller, D., Plaschke, K., Desensitization of brain insulin receptor. Effect on glucose/energy and related metabolism (1994) J Neural Transm Suppl, 44, pp. 259-268
• Aguado-Llera, D., Arilla-Ferreiro, E., Campos-Barros, A., Puebla-Jimenez, L., Barrios, V., Protective effects of insulin-like growth factor-I on the somatostatinergic system in the temporal cortex of beta-amyloid-treated rats (2005) J Neurochem, 92, pp. 607-615
• Crews, F.T., McElhaney, R., Freund, G., Ballinger Jr., W.E., Raizada, M.K., Insulin-like growth factor I receptor binding in brains of Alzheimer's and alcoholic patients (1992) J Neurochem, 58, pp. 1205-1210
• Hoyer, S., Somatostatin and Alzheimer's disease (1987) J Neurol, 234, pp. 266-267
• De Ferrari, G.V., Moon, R.T., The ups and downs of Wnt signaling in prevalent neurological disorders (2006) Oncogene, 25, pp. 7545-7553
• Balaraman, Y., Limaye, A.R., Levey, A.I., Srinivasan, S., Glycogen synthase kinase 3beta and Alzheimer's disease: Pathophysiological and therapeutic significance (2006) Cell Mol Life Sci, 63, pp. 1226-1235
• Widelitz, R., Wnt signaling through canonical and non-canonical pathways: Recent progress (2005) Growth Factors, 23, pp. 111-116
• Cerpa, W., Dinamarca, M.C., Inestrosa, N.C., Structure-function implications in Alzheimer's disease: Effect of Abeta oligomers at central synapses (2008) Curr Alzheimer Res, 5, pp. 233-243
• Mercado-Gomez, O., Hernandez-Fonseca, K., Villavicencio-Queijeiro, A., Massieu, L., Chimal-Monroy, J., Inhibition of Wnt and PI3K signaling modulates GSK-3beta activity and induces morphological changes in cortical neurons: Role of tau phosphorylation (2008) Neurochem Res, 33, pp. 1599-1609
• Magdesian, M.H., Carvalho, M.M., Mendes, F.A., Saraiva, L.M., Juliano, M.A., Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt/beta-catenin signaling (2008) J Biol Chem, 283, pp. 9359-9368
• Esposito, G., Scuderi, C., Lu, J., Savani, C., De Filippis, D., S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells (2008) J Cell Mol Med, 12, pp. 914-927
• Ferrero, A., Cereseto, M., Sifonios, L., The relationship between the Wnt signaling and the psychiatric diseases (2006) Vertex, 17, pp. 165-171
• De Ferrari, G.V., Papassotiropoulos, A., Biechele, T., Wavrant De-Vrieze, F., Avila, M.E., Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer's disease (2007) Proc Natl Acad Sci U S A, 104, pp. 9434-9439
• Inestrosa, N.C., Varela-Nallar, L., Grabowski, C.P., Colombres, M., Synaptotoxicity in Alzheimer's disease: The Wnt signaling pathway as a molecular target (2007) IUBMB Life, 59, pp. 316-321
• Maiese, K., Chong, Z.Z., Shang, Y.C., Mechanistic insights into diabetes mellitus and oxidative stress (2007) Curr Med Chem, 14, pp. 1729-1738
• Repetto, E., Yoon, I.S., Zheng, H., Kang, D.E., Presenilin 1 regulates epidermal growth factor receptor turnover and signaling in the endosomallysosomal pathway (2007) J Biol Chem, 282, pp. 31504-31516
• Fuentealba, R.A., Farias, G., Scheu, J., Bronfman, M., Marzolo, M.P., Signal transduction during amyloid-beta-peptide neurotoxicity: Role in Alzheimer disease (2004) Brain Res Brain Res Rev, 47, pp. 275-289
• Inestrosa, N.C., Urra, S., Colombres, M., Acetylcholinesterase (AChE)- amyloid-beta-peptide complexes in Alzheimer's disease. the Wnt signaling pathway (2004) Curr Alzheimer Res, 1, pp. 249-254
• De Ferrari, G.V., Inestrosa, N.C., Wnt signaling function in Alzheimer's disease (2000) Brain Res Brain Res Rev, 33, pp. 1-12
• Inestrosa, N.C., Alvarez, A., Godoy, J., Reyes, A., De Ferrari, G.V., Acetylcholinesterase-amyloid-beta-peptide interaction and Wnt signaling involvement in Abeta neurotoxicity (2000) Acta Neurol Scand Suppl, 176, pp. 53-59
• Small, D.H., Alzheimer Symposium. Gamma-secretase, presenilins and WNT proteins (2000) IDrugs, 3, pp. 740-741
• De Strooper, B., Annaert, W., Where Notch and Wnt signaling meet. The presenilin hub (2001) J Cell Biol, 152, pp. F17-F20
• Caricasole, A., Copani, A., Caruso, A., Caraci, F., Iacovelli, L., The Wnt pathway, cell-cycle activation and beta-amyloid: Novel therapeutic strategies in Alzheimer's disease? (2003) Trends Pharmacol Sci, 24, pp. 233-238
• De Ferrari, G.V., Chacon, M.A., Barria, M.I., Garrido, J.L., Godoy, J.A., Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils (2003) Mol Psychiatry, 8, pp. 195-208
• Grilli, M., Ferrari Toninelli, G., Uberti, D., Spano, P., Memo, M., Alzheimer's disease linking neurodegeneration with neurodevelopment (2003) Funct Neurol, 18, pp. 145-148
• Selkoe, D., Kopan, R., Notch and Presenilin: Regulated intramembrane proteolysis links development and degeneration (2003) Annu Rev Neurosci, 26, pp. 565-597
• Alvarez, A.R., Godoy, J.A., Mullendorff, K., Olivares, G.H., Bronfman, M., Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons (2004) Exp Cell Res, 297, pp. 186-196
• Busby, V., Goossens, S., Nowotny, P., Hamilton, G., Smemo, S., Alpha- T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease (2004) Neuromolecular Med, 5, pp. 133-146
• Caricasole, A., Copani, A., Caraci, F., Aronica, E., Rozemuller, A.J., Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain (2004) J Neurosci, 24, pp. 6021-6027
• Chong, Z.Z., Maiese, K., Targeting WNT, protein kinase B, and mitochondrial membrane integrity to foster cellular survival in the nervous system (2004) Histol Histopathol, 19, pp. 495-504
• Toledo, E.M., Colombres, M., Inestrosa, N.C., Wnt signaling in neuroprotection and stem cell differentiation (2008) Prog Neurobiol, 86, pp. 281-296
• Boonen, R.A., van Tijn, P., Zivkovic, D., Wnt signaling in Alzheimer's disease: Up or down, that is the question (2009) Ageing Res Rev, 8, pp. 71-82
• Cairney, C.J., Sanguinetti, G., Ranghini, E., Chantry, A.D., Nostro, M.C., A systems biology approach to Down syndrome: Identification of Notch/Wnt dysregulation in a model of stem cells aging (2009) Biochim Biophys Acta, 1792, pp. 353-363
• Caricasole, A., Bakker, A., Copani, A., Nicoletti, F., Gaviraghi, G., Two sides of the same coin: Wnt signaling in neurodegeneration and neurooncology (2005) Biosci Rep, 25, pp. 309-327
• Lee, E.O., Shin, Y.J., Chong, Y.H., Mechanisms involved in prostaglandin E2- mediated neuroprotection against TNF-alpha: Possible involvement of multiple signal transduction and beta-catenin/T-cell factor (2004) J Neuroimmunol, 155, pp. 21-31
• Doble, B.W., Woodgett, J.R., GSK-3: Tricks of the trade for a multi-tasking kinase (2003) J Cell Sci, 116, pp. 1175-1186
• Anderton, B.H., Dayanandan, R., Killick, R., Lovestone, S., Does dysregulation of the Notch and wingless/Wnt pathways underlie the pathogenesis of Alzheimer's disease? (2000) Mol Med Today, 6, pp. 54-59
• Weihl, C.C., Ghadge, G.D., Kennedy, S.G., Hay, N., Miller, R.J., Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB (1999) J Neurosci, 19, pp. 5360-5369
• Ray, A., Dhar, S., Shakya, A., Ray, P., Okada, Y., SAF-3, a novel splice variant of the SAF-1/MAZ/Pur-1 family, is expressed during inflammation (2009) FEBS J
• Jordan-Sciutto, K.L., Dragich, J.M., Caltagarone, J., Hall, D.J., Bowser, R., Fetal Alz-50 clone 1 (FAC1) protein interacts with the Myc-associated zinc finger protein (ZF87/MAZ) and alters its transcriptional activity (2000) Biochemistry, 39, pp. 3206-3215
• Bowden, N.A., Weidenhofer, J., Scott, R.J., Schall, U., Todd, J., Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia (2006) Schizophr Res, 82, pp. 175-183
• Bataller, L., Wade, D.F., Graus, F., Rosenfeld, M.R., Dalmau, J., The MAZ protein is an autoantigen of Hodgkin's disease and paraneoplastic cerebellar dysfunction (2003) Ann Neurol, 53, pp. 123-127
• Sajan, F.D., Martiniuk, F., Marcus, D.L., Frey II, W.H., Hite, R., Apoptotic gene expression in Alzheimer's disease hippocampal tissue (2007) Am J Alzheimers Dis Other Demen, 22, pp. 319-328
• Lim, A.C., Qi, R.Z., Cyclin-dependent kinases in neural development and degeneration (2003) J Alzheimers Dis, 5, pp. 329-335
• Jordan-Sciutto, K.L., Malaiyandi, L.M., Bowser, R., Altered distribution of cell cycle transcriptional regulators during Alzheimer disease (2002) J Neuropathol Exp Neurol, 61, pp. 358-367
• Jordan-Sciutto, K., Rhodes, J., Bowser, R., Altered subcellular distribution of transcriptional regulators in response to Abeta peptide and during Alzheimer's disease (2001) Mech Ageing Dev, 123, pp. 11-20
• Motonaga, K., Itoh, M., Hirayama, A., Hirano, S., Becker, L.E., Upregulation of E2F-1 in Down's syndrome brain exhibiting neuropathological features of Alzheimer-type dementia (2001) Brain Res, 905, pp. 250-253
• Putzer, B.M., Targeting E2F1 Death Signaling: Opposing Role in Cancer Control and Neurodegeneration (2006) Discov Med, 6, pp. 123-127
• Strachan, G.D., Koike, M.A., Siman, R., Hall, D.J., Jordan-Sciutto, K.L., E2F1 induces cell death, calpain activation, and MDMX degradation in a transcription independent manner implicating a novel role for E2F1 in neuronal loss in SIV encephalitis (2005) J Cell Biochem, 96, pp. 728-740
• Fortin, A., MacLaurin, J.G., Arbour, N., Cregan, S.P., Kushwaha, N., The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1 (2004) J Biol Chem, 279, pp. 28706-28714
• Jordan-Sciutto, K.L., Wang, G., Murphey-Corb, M., Wiley, C.A., Cell cycle proteins exhibit altered expression patterns in lentiviral-associated encephalitis (2002) J Neurosci, 22, pp. 2185-2195
• Jordan-Sciutto, K.L., Murray Fenner, B.A., Wiley, C.A., Achim, C.L., Response of cell cycle proteins to neurotrophic factor and chemokine stimulation in human neuroglia (2001) Exp Neurol, 167, pp. 205-214
• Jordan-Sciutto, K.L., Wang, G., Murphy-Corb, M., Wiley, C.A., Induction of cell-cycle regulators in simian immunodeficiency virus encephalitis (2000) Am J Pathol, 157, pp. 497-507
• Strachan, G.D., Kopp, A.S., Koike, M.A., Morgan, K.L., Jordan-Sciutto, K.L., Chemokine- and neurotrophic factor-induced changes in E2F1 localization and phosphorylation of the retinoblastoma susceptibility gene product (pRb) occur by distinct mechanisms in murine cortical cultures (2005) Exp Neurol, 193, pp. 455-468
• Verdaguer, E., Susana Gde, A., Clemens, A., Pallas, M., Camins, A., Implication of the transcription factor E2F-1 in the modulation of neuronal apoptosis (2007) Biomed Pharmacother, 61, pp. 390-399
• Ranganathan, S., Bowser, R., Alterations in G(1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis (2003) Am J Pathol, 162, pp. 823-835
• MacManus, J.P., Jian, M., Preston, E., Rasquinha, I., Webster, J., Absence of the transcription factor E2F1 attenuates brain injury and improves behavior after focal ischemia in mice (2003) J Cereb Blood Flow Metab, 23, pp. 1020-1028
• Konishi, Y., Bonni, A., The E2F-Cdc2 cell-cycle pathway specifically mediates activity deprivation-induced apoptosis of postmitotic neurons (2003) J Neurosci, 23, pp. 1649-1658
• Cooper-Kuhn, C.M., Vroemen, M., Brown, J., Ye, H., Thompson, M.A., Impaired adult neurogenesis in mice lacking the transcription factor E2F1 (2002) Mol Cell Neurosci, 21, pp. 312-323
• MacGibbon, G.A., Lawlor, P.A., Walton, M., Sirimanne, E., Faull, R.L., Expression of Fos, Jun, and Krox family proteins in Alzheimer's disease (1997) Exp Neurol, 147, pp. 316-332
• Revest, J.M., Di Blasi, F., Kitchener, P., Rouge-Pont, F., Desmedt, A., The MAPK pathway and Egr-1 mediate stress-related behavioral effects of glucocorticoids (2005) Nat Neurosci, 8, pp. 664-672
• Illing, R.B., Michler, S.A., Kraus, K.S., Laszig, R., Transcription factor modulation and expression in the rat auditory brainstem following electrical intracochlear stimulation (2002) Exp Neurol, 175, pp. 226-244
• Bozon, B., Davis, S., Laroche, S., A requirement for the immediate early gene zif268 in reconsolidation of recognition memory after retrieval (2003) Neuron, 40, pp. 695-701
• Knapska, E., Kaczmarek, L., A gene for neuronal plasticity in the mammalian brain: Zif268/Egr-1/NGFI-A/Krox-24/TIS8/ZENK? (2004) Prog Neurobiol, 74, pp. 183-211
• Bozon, B., Kelly, A., Josselyn, S.A., Silva, A.J., Davis, S., MAPK, CREB and zif268 are all required for the consolidation of recognition memory (2003) Philos Trans R Soc Lond B Biol Sci, 358, pp. 805-814
• Alder, J., Thakker-Varia, S., Bangasser, D.A., Kuroiwa, M., Plummer, M.R., Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity (2003) J Neurosci, 23, pp. 10800-10808
• Illing, R.B., Activity-dependent plasticity in the adult auditory brainstem (2001) Audiol Neurootol, 6, pp. 319-345
• Poirier, R., Cheval, H., Mailhes, C., Garel, S., Charnay, P., Distinct functions of egr gene family members in cognitive processes (2008) Front Neurosci, 2, pp. 47-55
• Poirier, R., Cheval, H., Mailhes, C., Charnay, P., Davis, S., Paradoxical role of an egr transcription factor family member, egr2/krox20, in learning and memory (2007) Front Behav Neurosci, 1, p. 6
• Desjardins, S., Mayo, W., Vallee, M., Hancock, D., Le Moal, M., Effect of aging on the basal expression of c-Fos, c-Jun, and Egr-1 proteins in the hippocampus (1997) Neurobiol Aging, 18, pp. 37-44
• Dong, S., Replogle, K.L., Hasadsri, L., Imai, B.S., Yau, P.M., Discrete molecular states in the brain accompany changing responses to a vocal signal (2009) Proc Natl Acad Sci U S A, 106, pp. 11364-11369
• Velho, T.A., Mello, C.V., Synapsins are late activity-induced genes regulated by birdsong (2008) J Neurosci, 28, pp. 11871-11882
• Velho, T.A., Lovell, P., Mello, C.V., Enriched expression and developmental regulation of the middle-weight neurofilament (NF-M) gene in song control nuclei of the zebra finch (2007) J Comp Neurol, 500, pp. 477-497
• Zhu, M.X., Multiple roles of calmodulin and other Ca(2+)-binding proteins in the functional regulation of TRP channels (2005) Pflugers Arch, 451, pp. 105-115
• Zhou, H., Yu, K., McCoy, K.L., Lee, A., Molecular mechanism for divergent regulation of Cav1.2 Ca2+ channels by calmodulin and Ca2+-binding protein- 1 (2005) J Biol Chem, 280, pp. 29612-29619
• Wingard, J.N., Chan, J., Bosanac, I., Haeseleer, F., Palczewski, K., Structural analysis of Mg2+ and Ca2+ binding to CaBP1, a neuron-specific regulator of calcium channels (2005) J Biol Chem, 280, pp. 37461-37470
• Li, C., Chan, J., Haeseleer, F., Mikoshiba, K., Palczewski, K., Structural insights into Ca2+-dependent regulation of inositol 1,4,5-trisphosphate receptors by CaBP1 (2009) J Biol Chem, 284, pp. 2472-2481
• Chen, M.L., Chen, Y.C., Peng, I.W., Kang, R.L., Wu, M.P., Ca2+ binding protein-1 inhibits Ca2+ currents and exocytosis in bovine chromaffin cells (2008) J Biomed Sci, 15, pp. 169-181
• Tippens, A.L., Lee, A., Caldendrin, a neuron-specific modulator of Cav/1.2 (L-type) Ca2+ channels (2007) J Biol Chem, 282, pp. 8464-8473
• Haynes, L.P., Fitzgerald, D.J., Wareing, B., O'Callaghan, D.W., Morgan, A., Analysis of the interacting partners of the neuronal calcium-binding proteins L-CaBP1, hippocalcin, NCS-1 and neurocalcin delta (2006) Proteomics, 6, pp. 1822-1832
• Lautermilch, N.J., Few, A.P., Scheuer, T., Catterall, W.A., Modulation of CaV2.1 channels by the neuronal calcium-binding protein visinin-like protein- 2 (2005) J Neurosci, 25, pp. 7062-7070
• Haeseleer, F., Imanishi, Y., Maeda, T., Possin, D.E., Maeda, A., Essential role of Ca2+-binding protein 4, a Cav1.4 channel regulator, in photoreceptor synaptic function (2004) Nat Neurosci, 7, pp. 1079-1087
• Eran, A., Graham, K.R., Vatalaro, K., McCarthy, J., Collins, C., Comment on "Autistic-like phenotypes in Cadps2-knockout mice and aberrant CADPS2 splicing in autistic patients" (2009) J Clin Invest, 119, pp. 679-680. , author reply 680-671
• Sadakata, T., Furuichi, T., Developmentally regulated Ca(2+)-dependent activator protein for secretion 2 (CAPS2) is involved in BDNF secretion and is associated with autism susceptibility (2009) Cerebellum
• Sadakata, T., Washida, M., Furuichi, T., Alternative splicing variations in mouse CAPS2: Differential expression and functional properties of splicing variants (2007) BMC Neurosci, 8, p. 25
• Sadakata, T., Washida, M., Iwayama, Y., Shoji, S., Sato, Y., Autistic-like phenotypes in Cadps2-knockout mice and aberrant CADPS2 splicing in autistic patients (2007) J Clin Invest, 117, pp. 931-943
• Sadakata, T., Kakegawa, W., Mizoguchi, A., Washida, M., Katoh-Semba, R., Impaired cerebellar development and function in mice lacking CAPS2, a protein involved in neurotrophin release (2007) J Neurosci, 27, pp. 2472-2482
• Sadakata, T., Washida, M., Morita, N., Furuichi, T., Tissue distribution of Ca2+-dependent activator protein for secretion family members CAPS1 and CAPS2 in mice (2007) J Histochem Cytochem, 55, pp. 301-311
• Feng, G., Krejci, E., Molgo, J., Cunningham, J.M., Massoulie, J., Genetic analysis of collagen Q: Roles in acetylcholinesterase and butyrylcholinesterase assembly and in synaptic structure and function (1999) J Cell Biol, 144, pp. 1349-1360
• Fritschy, J.M., Schweizer, C., Brunig, I., Luscher, B., Pre- and post-synaptic mechanisms regulating the clustering of type A gamma-aminobutyric acid receptors (GABAA receptors) (2003) Biochem Soc Trans, 31, pp. 889-892
• Banks, G.B., Chamberlain, J.S., Froehner, S.C., Truncated dystrophins can influence neuromuscular synapse structure (2009) Mol Cell Neurosci, 40, pp. 433-441
• Fradkin, L.G., Baines, R.A., van der Plas, M.C., Noordermeer, J.N., The dystrophin Dp186 isoform regulates neurotransmitter release at a central synapse in Drosophila (2008) J Neurosci, 28, pp. 5105-5114
• Bogdanik, L., Framery, B., Frolich, A., Franco, B., Mornet, D., Muscle dystroglycan organizes the postsynapse and regulates presynaptic neurotransmitter release at the Drosophila neuromuscular junction (2008) PLoS One, 3, pp. e2084
• Minatel, E., Neto, H.S., Marques, M.J., Acetylcholine receptor distribution and synapse elimination at the developing neuromuscular junction of mdx mice (2003) Muscle Nerve, 28, pp. 561-569
• Marchand, S., Stetzkowski-Marden, F., Cartaud, J., Differential targeting of components of the dystrophin complex to the postsynaptic membrane (2001) Eur J Neurosci, 13, pp. 221-229
• Monroig, O., Rotllant, J., Sanchez, E., Cerda-Reverter, J.M., Tocher, D.R., Expression of long-chain polyunsaturated fatty acid (LC-PUFA) biosynthesis genes during zebrafish Danio rerio early embryogenesis (2009) Biochim Biophys Acta
• Fernandez, M., Segura, M.F., Sole, C., Colino, A., Comella, J.X., Lifeguard/neuronal membrane protein 35 regulates Fas ligand-mediated apoptosis in neurons via microdomain recruitment (2007) J Neurochem, 103, pp. 190-203
• Reimers, K., Choi, C.Y., Mau-Thek, E., Vogt, P.M., Sequence analysis shows that Lifeguard belongs to a new evolutionarily conserved cytoprotective family (2006) Int J Mol Med, 18, pp. 729-734
• Chen, W., Lee, J., Cho, S.Y., Fine, H.A., Proteasome-mediated destruction of the cyclin a/cyclin-dependent kinase 2 complex suppresses tumor cell growth in vitro and in vivo (2004) Cancer Res, 64, pp. 3949-3957
• Somia, N.V., Schmitt, M.J., Vetter, D.E., Van Antwerp, D., Heinemann, S.F., LFG: An anti-apoptotic gene that provides protection from Fas-mediated cell death (1999) Proc Natl Acad Sci U S A, 96, pp. 12667-12672
• Lopez-Bendito, G., Shigemoto, R., Kulik, A., Paulsen, O., Fairen, A., Expression and distribution of metabotropic GABA receptor subtypes GABABR1 and GABABR2 during rat neocortical development (2002) Eur J Neurosci, 15, pp. 1766-1778
• Fatemi, S.H., Folsom, T.D., Reutiman, T.J., Thuras, P.D., Expression of GABA(B) receptors is altered in brains of subjects with autism (2009) Cerebellum, 8, pp. 64-69
• Correa, S.A., Munton, R., Nishimune, A., Fitzjohn, S., Henley, J.M., Development of GABAB subunits and functional GABAB receptors in rat cultured hippocampal neurons (2004) Neuropharmacology, 47, pp. 475-484
• Straessle, A., Loup, F., Arabadzisz, D., Ohning, G.V., Fritschy, J.M., Rapid and long-term alterations of hippocampal GABAB receptors in a mouse model of temporal lobe epilepsy (2003) Eur J Neurosci, 18, pp. 2213-2226
• Mead, A.N., Morris, H.V., Dixon, C.I., Rulten, S.L., Mayne, L.V., AMPA receptor GluR2, but not GluR1, subunit deletion impairs emotional response conditioning in mice (2006) Behav Neurosci, 120, pp. 241-248
• Beveridge, N.J., Tooney, P.A., Carroll, A.P., Gardiner, E., Bowden, N., Dysregulation of miRNA 181b in the temporal cortex in schizophrenia (2008) Hum Mol Genet, 17, pp. 1156-1168
• Le-Niculescu, H., Balaraman, Y., Patel, S., Tan, J., Sidhu, K., Towards understanding the schizophrenia code: An expanded convergent functional genomics approach (2007) Am J Med Genet B Neuropsychiatr Genet, 144 B, pp. 129-158
• Dhar, S.S., Liang, H.L., Wong-Riley, M.T., Nuclear respiratory factor 1 coregulates AMPA glutamate receptor subunit 2 and cytochrome c oxidase: Tight coupling of glutamatergic transmission and energy metabolism in neurons (2009) J Neurochem, 108, pp. 1595-1606
• Mead, A.N., Stephens, D.N., Involvement of AMPA receptor GluR2 subunits in stimulus-reward learning: Evidence from glutamate receptor gria2 knock-out mice (2003) J Neurosci, 23, pp. 9500-9507
• Williams, C., Mehrian Shai, R., Wu, Y., Hsu, Y.H., Sitzer, T., Transcriptome analysis of synaptoneurosomes identifies neuroplasticity genes overexpressed in incipient Alzheimer's disease (2009) PLoS One, 4, pp. e4936
• Perlis, R.H., Smoller, J.W., Ferreira, M.A., McQuillin, A., Bass, N., A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder (2009) Am J Psychiatry, 166, pp. 718-725
• Medvedev, N.I., Rodriguez-Arellano, J.J., Popov, V.I., Davies, H.A., Tigaret, C.M., The glutamate receptor 2 subunit controls post-synaptic density complexity and spine shape in the dentate gyrus (2008) Eur J Neurosci, 27, pp. 315-325
• Hou, Q., Zhang, D., Jarzylo, L., Huganir, R.L., Man, H.Y., Homeostatic regulation of AMPA receptor expression at single hippocampal synapses (2008) Proc Natl Acad Sci U S A, 105, pp. 775-780
• Heine, M., Thoumine, O., Mondin, M., Tessier, B., Giannone, G., Activity-independent and subunit-specific recruitment of functional AMPA receptors at neurexin/neuroligin contacts (2008) Proc Natl Acad Sci U S A, 105, pp. 20947-20952
• Bagal, A.A., Kao, J.P., Tang, C.M., Thompson, S.M., Long-term potentiation of exogenous glutamate responses at single dendritic spines (2005) Proc Natl Acad Sci U S A, 102, pp. 14434-14439
• Passafaro, M., Nakagawa, T., Sala, C., Sheng, M., Induction of dendritic spines by an extracellular domain of AMPA receptor subunit GluR2 (2003) Nature, 424, pp. 677-681
• Tsim, K.W., Choi, R.C., Siow, N.L., Cheng, A.W., Ling, K.K., ATP induces post-synaptic gene expressions in vertebrate skeletal neuromuscular junctions (2003) J Neurocytol, 32, pp. 603-617
• Zhang, G.C., Mao, L.M., Liu, X.Y., Parelkar, N.K., Arora, A., In vivo regulation of Homer1a expression in the striatum by cocaine (2007) Mol Pharmacol, 71, pp. 1148-1158
• Todd, K.J., Auld, D.S., Robitaille, R., Neurotrophins modulate neuron-glia interactions at a vertebrate synapse (2007) Eur J Neurosci, 25, pp. 1287-1296
• Mao, L., Yang, L., Tang, Q., Samdani, S., Zhang, G., The scaffold protein Homer1b/c links metabotropic glutamate receptor 5 to extracellular signal-regulated protein kinase cascades in neurons (2005) J Neurosci, 25, pp. 2741-2752
• Ogasawara, H., Doi, T., Kawato, M., Systems biology perspectives on cerebellar long-term depression (2008) Neurosignals, 16, pp. 300-317
• Faraut, B., Barbier, J., Ravel-Chapuis, A., Doyennette, M.A., Jandrot-Perrus, M., Thrombin downregulates muscle acetylcholine receptors via an IP3 signaling pathway by activating its G-protein-coupled protease-activated receptor-1 (2003) J Cell Physiol, 196, pp. 105-112
• Sakae, N., Yamasaki, N., Kitaichi, K., Fukuda, T., Yamada, M., Mice lacking the schizophrenia-associated protein FEZ1 manifest hyperactivity and enhanced responsiveness to psychostimulants (2008) Hum Mol Genet, 17, pp. 3191-3203
• Konno, D., Ko, J.A., Usui, S., Hori, K., Maruoka, H., The postsynaptic density and dendritic raft localization of PSD-Zip70, which contains an Nmyristoylation sequence and leucine-zipper motifs (2002) J Cell Sci, 115, pp. 4695-4706
• Bardoni, B., Giglio, S., Schenck, A., Rocchi, M., Mandel, J.L., Assignment of NUFIP1 (nuclear FMRP interacting protein 1) gene to chromosome 13q14 and assignment of a pseudogene to chromosome 6q12 (2000) Cytogenet Cell Genet, 89, pp. 11-13
• Bardoni, B., Schenck, A., Mandel, J.L., A novel RNA-binding nuclear protein that interacts with the fragile X mental retardation (FMR1) protein (1999) Hum Mol Genet, 8, pp. 2557-2566
• Bardoni, B., Willemsen, R., Weiler, I.J., Schenck, A., Severijnen, L.A., NUFIP1 (nuclear FMRP interacting protein 1) is a nucleocytoplasmic shuttling protein associated with active synaptoneurosomes (2003) Exp Cell Res, 289, pp. 95-107
• Macauley, S.L., Wozniak, D.F., Kielar, C., Tan, Y., Cooper, J.D., Cerebellar pathology and motor deficits in the palmitoyl protein thioesterase 1-deficient mouse (2009) Exp Neurol, 217, pp. 124-135
• Tardy, C., Sabourdy, F., Garcia, V., Jalanko, A., Therville, N., Palmitoyl protein thioesterase 1 modulates tumor necrosis factor alpha-induced apoptosis (2009) Biochim Biophys Acta, 1793, pp. 1250-1258
• Kim, S.J., Zhang, Z., Sarkar, C., Tsai, P.C., Lee, Y.C., Palmitoyl protein thioesterase-1 deficiency impairs synaptic vesicle recycling at nerve terminals, contributing to neuropathology in humans and mice (2008) J Clin Invest, 118, pp. 3075-3086
• Zhang, Z., Lee, Y.C., Kim, S.J., Choi, M.S., Tsai, P.C., Production of lysophosphatidylcholine by cPLA2 in the brain of mice lacking PPT1 is a signal for phagocyte infiltration (2007) Hum Mol Genet, 16, pp. 837-847
• Ramadan, H., Al-Din, A.S., Ismail, A., Balen, F., Varma, A., Adult neuronal ceroid lipofuscinosis caused by deficiency in palmitoyl protein thioesterase 1 (2007) Neurology, 68, pp. 387-388
• Qiao, X., Lu, J.Y., Hofmann, S.L., Gene expression profiling in a mouse model of infantile neuronal ceroid lipofuscinosis reveals upregulation of immediate early genes and mediators of the inflammatory response (2007) BMC Neurosci, 8, p. 95
• Lyly, A., von Schantz, C., Salonen, T., Kopra, O., Saarela, J., Glycosylation, transport, and complex formation of palmitoyl protein thioesterase 1 (PPT1)-distinct characteristics in neurons (2007) BMC Cell Biol, 8, p. 22
• Kielar, C., Maddox, L., Bible, E., Pontikis, C.C., Macauley, S.L., Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis (2007) Neurobiol Dis, 25, pp. 150-162
• Kalviainen, R., Eriksson, K., Losekoot, M., Sorri, I., Harvima, I., Juvenile-onset neuronal ceroid lipofuscinosis with infantile CLN1 mutation and palmitoyl-protein thioesterase deficiency (2007) Eur J Neurol, 14, pp. 369-372
• Ahtiainen, L., Kolikova, J., Mutka, A.L., Luiro, K., Gentile, M., Palmitoyl protein thioesterase 1 (Ppt1)-deficient mouse neurons show alterations in cholesterol metabolism and calcium homeostasis prior to synaptic dysfunction (2007) Neurobiol Dis, 28, pp. 52-64
• Zhang, Z., Lee, Y.C., Kim, S.J., Choi, M.S., Tsai, P.C., Palmitoyl-protein thioesterase-1 deficiency mediates the activation of the unfolded protein response and neuronal apoptosis in INCL (2006) Hum Mol Genet, 15, pp. 337-346
• Bible, E., Gupta, P., Hofmann, S.L., Cooper, J.D., Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis (2004) Neurobiol Dis, 16, pp. 346-359
• Ahtiainen, L., Van Diggelen, O.P., Jalanko, A., Kopra, O., Palmitoyl protein thioesterase 1 is targeted to the axons in neurons (2003) J Comp Neurol, 455, pp. 368-377
• Francis, S.C., Sunshine, C., Kirk, K.L., Coordinate regulation of catecholamine uptake by rab3 and phosphoinositide 3-kinase (2002) J Biol Chem, 277, pp. 7816-7823
• Schluter, O.M., Basu, J., Sudhof, T.C., Rosenmund, C., Rab3 superprimes synaptic vesicles for release: Implications for short-term synaptic plasticity (2006) J Neurosci, 26, pp. 1239-1246
• Sons, M.S., Plomp, J.J., Rab3A deletion selectively reduces spontaneous neurotransmitter release at the mouse neuromuscular synapse (2006) Brain Res, 1089, pp. 126-134
• Nishioka, H., Haraoka, J., Significance of immunohistochemical expression of Rab3B and SNAP-25 in growth hormone-producing pituitary adenomas (2005) Acta Neuropathol, 109, pp. 598-602
• Schluter, O.M., Schmitz, F., Jahn, R., Rosenmund, C., Sudhof, T.C., A complete genetic analysis of neuronal Rab3 function (2004) J Neurosci, 24, pp. 6629-6637
• Matsuno, A., Itoh, J., Takekoshi, S., Itoh, Y., Ohsugi, Y., Dynamics of subcellular organelles, growth hormone, Rab3B, SNAP-25, and syntaxin in rat pituitary cells caused by growth hormone releasing hormone and somatostatin (2003) Microsc Res Tech, 62, pp. 232-239
• Sidhu, R.S., Bhullar, R.P., Rab3B in human platelet is membrane bound and interacts with Ca(2+)/calmodulin (2001) Biochem Biophys Res Commun, 289, pp. 1039-1043
• Masumoto, N., Ikebuchi, Y., Tahara, M., Yokoi, T., Tasaka, K., Expression of Rab3A in the cortical region in mouse metaphase II eggs (1998) J Exp Zool, 280, pp. 91-96
• Madison, D.L., Kruger, W.H., Kim, T., Pfeiffer, S.E., Differential expression of rab3 isoforms in oligodendrocytes and astrocytes (1996) J Neurosci Res, 45, pp. 258-268
• Grabs, D., Bergmann, M., Urban, M., Post, A., Gratzl, M., Rab3 proteins and SNAP-25, essential components of the exocytosis machinery in conventional synapses, are absent from ribbon synapses of the mouse retina (1996) Eur J Neurosci, 8, pp. 162-168
• Stettler, O., Nothias, F., Tavitian, B., Vernier, P., Double in situ hybridization reveals overlapping neuronal populations expressing the low molecular weight GTPases Rab3a and Rab3b in Rat brain (1995) Eur J Neurosci, 7, pp. 702-713
• Redecker, P., Cetin, Y., Grube, D., Differential distribution of synaptotagmin I and rab3 in the anterior pituitary of four mammalian species (1995) Neuroendocrinology, 62, pp. 101-110
• Fischer von Mollard, G., Stahl, B., Khokhlatchev, A., Sudhof, T.C., Jahn, R., Rab3C is a synaptic vesicle protein that dissociates from synaptic vesicles after stimulation of exocytosis (1994) J Biol Chem, 269, pp. 10971-10974
• Lledo, P.M., Vernier, P., Vincent, J.D., Mason, W.T., Zorec, R., Inhibition of Rab3B expression attenuates Ca(2+)-dependent exocytosis in rat anterior pituitary cells (1993) Nature, 364, pp. 540-544
• Lledo, P.M., Johannes, L., Vernier, P., Henry, J.P., Vincent, J.D., Calcium-dependent regulated secretion is controlled by GTPase Rab3 in neuroendocrine cells (1993) C R Seances Soc Biol Fil, 187, pp. 726-736
• Karniguian, A., Zahraoui, A., Tavitian, A., Identification of small GTPbinding rab proteins in human platelets: Thrombin-induced phosphorylation of rab3B, rab6, and rab8 proteins (1993) Proc Natl Acad Sci U S A, 90, pp. 7647-7651
• Weidenhofer, J., Scott, R.J., Tooney, P.A., Investigation of the expression of genes affecting cytomatrix active zone function in the amygdala in schizophrenia: Effects of antipsychotic drugs (2009) J Psychiatr Res, 43, pp. 282-290
• Fujimoto, K., Shibasaki, T., Yokoi, N., Kashima, Y., Matsumoto, M., Piccolo, a Ca2+ sensor in pancreatic beta-cells. Involvement of cAMPGEFII. Rim2.Piccolo complex in cAMP-dependent exocytosis (2002) J Biol Chem, 277, pp. 50497-50502
• Kashima, Y., Miki, T., Shibasaki, T., Ozaki, N., Miyazaki, M., Critical role of cAMP-GEFII-Rim2 complex in incretin-potentiated insulin secretion (2001) J Biol Chem, 276, pp. 46046-46053
• Ozaki, N., Shibasaki, T., Kashima, Y., Miki, T., Takahashi, K., CAMPGEFII is a direct target of cAMP in regulated exocytosis (2000) Nat Cell Biol, 2, pp. 805-811
• Brandstatter, J.H., Dick, O., Boeckers, T.M., The postsynaptic scaffold proteins ProSAP1/Shank2 and Homer1 are associated with glutamate receptor complexes at rat retinal synapses (2004) J Comp Neurol, 475, pp. 551-563
• Uemura, T., Mori, H., Mishina, M., Direct interaction of GluRdelta2 with Shank scaffold proteins in cerebellar Purkinje cells (2004) Mol Cell Neurosci, 26, pp. 330-341
• Bockers, T.M., Segger-Junius, M., Iglauer, P., Bockmann, J., Gundelfinger, E.D., Differential expression and dendritic transcript localization of Shank family members: Identification of a dendritic targeting element in the 39 untranslated region of Shank1 mRNA (2004) Mol Cell Neurosci, 26, pp. 182-190
• Qualmann, B., Boeckers, T.M., Jeromin, M., Gundelfinger, E.D., Kessels, M.M., Linkage of the actin cytoskeleton to the postsynaptic density via direct interactions of Abp1 with the ProSAP/Shank family (2004) J Neurosci, 24, pp. 2481-2495
• de Bartolomeis, A., Fiore, G., Postsynaptic density scaffolding proteins at excitatory synapse and disorders of synaptic plasticity: Implications for human behavior pathologies (2004) Int Rev Neurobiol, 59, pp. 221-254
• Hwang, J.I., Kim, H.S., Lee, J.R., Kim, E., Ryu, S.H., The interaction of phospholipase C-beta3 with Shank2 regulates mGluR-mediated calcium signal (2005) J Biol Chem, 280, pp. 12467-12473
• Bresler, T., Shapira, M., Boeckers, T., Dresbach, T., Futter, M., Postsynaptic density assembly is fundamentally different from presynaptic active zone assembly (2004) J Neurosci, 24, pp. 1507-1520
• Kim, J.Y., Han, W., Namkung, W., Lee, J.H., Kim, K.H., Inhibitory regulation of cystic fibrosis transmembrane conductance regulator aniontransporting activities by Shank2 (2004) J Biol Chem, 279, pp. 10389-10396
• Park, E., Na, M., Choi, J., Kim, S., Lee, J.R., The Shank family of postsynaptic density proteins interacts with and promotes synaptic accumulation of the beta PIX guanine nucleotide exchange factor for Rac1 and Cdc42 (2003) J Biol Chem, 278, pp. 19220-19229
• Kreienkamp, H.J., Soltau, M., Richter, D., Bockers, T., Interaction of Gprotein- coupled receptors with synaptic scaffolding proteins (2002) Biochem Soc Trans, 30, pp. 464-468
• Boeckers, T.M., Bockmann, J., Kreutz, M.R., Gundelfinger, E.D., ProSAP/ Shank proteins - a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease (2002) J Neurochem, 81, pp. 903-910
• Ehlers, M.D., Molecular morphogens for dendritic spines (2002) Trends Neurosci, 25, pp. 64-67
• Okamoto, P.M., Gamby, C., Wells, D., Fallon, J., Vallee, R.B., Dynamin isoform-specific interaction with the shank/ProSAP scaffolding proteins of the postsynaptic density and actin cytoskeleton (2001) J Biol Chem, 276, pp. 48458-48465
• Kreienkamp, H.J., Zitzer, H., Richter, D., Identification of proteins interacting with the rat somatostatin receptor subtype 2 (2000) J Physiol Paris, 94, pp. 193-198
• Tobaben, S., Sudhof, T.C., Stahl, B., The G protein-coupled receptor CL1 interacts directly with proteins of the Shank family (2000) J Biol Chem, 275, pp. 36204-36210
• Sheng, M., Kim, E., The Shank family of scaffold proteins (2000) J Cell Sci, 113 (PT 11), pp. 1851-1856
• Ehlers, M.D., Synapse structure: Glutamate receptors connected by the shanks (1999) Curr Biol, 9, pp. R848-R850
• Boeckers, T.M., Winter, C., Smalla, K.H., Kreutz, M.R., Bockmann, J., Proline-rich synapse-associated proteins ProSAP1 and ProSAP2 interact with synaptic proteins of the SAPAP/GKAP family (1999) Biochem Biophys Res Commun, 264, pp. 247-252
• Lim, S., Naisbitt, S., Yoon, J., Hwang, J.I., Suh, P.G., Characterization of the Shank family of synaptic proteins. Multiple genes, alternative splicing, and differential expression in brain and development (1999) J Biol Chem, 274, pp. 29510-29518
• Bajjalieh, S.M., Peterson, K., Linial, M., Scheller, R.H., Brain contains two forms of synaptic vesicle protein 2 (1993) Proc Natl Acad Sci U S A, 90, pp. 2150-2154
• Lynch, B.A., Lambeng, N., Nocka, K., Kensel-Hammes, P., Bajjalieh, S.M., The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam (2004) Proc Natl Acad Sci U S A, 101, pp. 9861-9866
• Bindra, P.S., Knowles, R., Buckley, K.M., Conservation of the amino acid sequence of SV2, a transmembrane transporter in synaptic vesicles and endocrine cells (1993) Gene, 137, pp. 299-302
• Schivell, A.E., Batchelor, R.H., Bajjalieh, S.M., Isoform-specific, calciumregulated interaction of the synaptic vesicle proteins SV2 and synaptotagmin (1996) J Biol Chem, 271, pp. 27770-27775
• Yao, J., Bajjalieh, S.M., Synaptic vesicle protein 2 binds adenine nucleotides (2008) J Biol Chem, 283, pp. 20628-20634
• Iezzi, M., Theander, S., Janz, R., Loze, C., Wollheim, C.B., SV2A and SV2C are not vesicular Ca2+ transporters but control glucose-evoked granule recruitment (2005) J Cell Sci, 118, pp. 5647-5660
• Lockhart, S.T., Mead, J.N., Pisano, J.M., Slonimsky, J.D., Birren, S.J., Nerve growth factor collaborates with myocyte-derived factors to promote development of presynaptic sites in cultured sympathetic neurons (2000) J Neurobiol, 42, pp. 460-476
• Hayashi, M., Yamamoto, A., Yatsushiro, S., Yamada, H., Futai, M., Synaptic vesicle protein SV2B, but not SV2A, is predominantly expressed and associated with microvesicles in rat pinealocytes (1998) J Neurochem, 71, pp. 356-365
• Scranton, T.W., Iwata, M., Carlson, S.S., The SV2 protein of synaptic vesicles is a keratan sulfate proteoglycan (1993) J Neurochem, 61, pp. 29-44
• Bajjalieh, S.M., Frantz, G.D., Weimann, J.M., McConnell, S.K., Scheller, R.H., Differential expression of synaptic vesicle protein 2 (SV2) isoforms (1994) J Neurosci, 14, pp. 5223-5235
• Custer, K.L., Austin, N.S., Sullivan, J.M., Bajjalieh, S.M., Synaptic vesicle protein 2 enhances release probability at quiescent synapses (2006) J Neurosci, 26, pp. 1303-1313
• Janz, R., Hofmann, K., Sudhof, T.C., SVOP, an evolutionarily conserved synaptic vesicle protein, suggests novel transport functions of synaptic vesicles (1998) J Neurosci, 18, pp. 9269-9281
• Dong, M., Liu, H., Tepp, W.H., Johnson, E.A., Janz, R., Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons (2008) Mol Biol Cell, 19, pp. 5226-5237
• Schivell, A.E., Mochida, S., Kensel-Hammes, P., Custer, K.L., Bajjalieh, S.M., SV2A and SV2C contain a unique synaptotagmin-binding site (2005) Mol Cell Neurosci, 29, pp. 56-64
• Janz, R., Goda, Y., Geppert, M., Missler, M., Sudhof, T.C., SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release (1999) Neuron, 24, pp. 1003-1016
• Lambeng, N., Grossmann, M., Chatelain, P., Fuks, B., Solubilization and immunopurification of rat brain synaptic vesicle protein 2A with maintained binding properties (2006) Neurosci Lett, 398, pp. 107-112
• Janz, R., Sudhof, T.C., SV2C is a synaptic vesicle protein with an unusually restricted localization: Anatomy of a synaptic vesicle protein family (1999) Neuroscience, 94, pp. 1279-1290
• Clegg, N., Ferguson, C., True, L.D., Arnold, H., Moorman, A., Molecular characterization of prostatic small-cell neuroendocrine carcinoma (2003) Prostate, 55, pp. 55-64
• Dong, M., Yeh, F., Tepp, W.H., Dean, C., Johnson, E.A., SV2 is the protein receptor for botulinum neurotoxin A (2006) Science, 312, pp. 592-596
• Leonoudakis, D., Conti, L.R., Radeke, C.M., McGuire, L.M., Vandenberg, C.A., A multiprotein trafficking complex composed of SAP97, CASK, Veli, and Mint1 is associated with inward rectifier Kir2 potassium channels (2004) J Biol Chem, 279, pp. 19051-19063
• Atasoy, D., Schoch, S., Ho, A., Nadasy, K.A., Liu, X., Deletion of CASK in mice is lethal and impairs synaptic function (2007) Proc Natl Acad Sci U S A, 104, pp. 2525-2530
• Klemmer, P., Smit, A.B., Li, K.W., Proteomics analysis of immunoprecipitated synaptic protein complexes (2009) J Proteomics, 72, pp. 82-90
• Hernandez-Ortega, K., Ferrera, P., Arias, C., Sequential expression of cellcycle regulators and Alzheimer's disease-related proteins in entorhinal cortex after hippocampal excitotoxic damage (2007) J Neurosci Res, 85, pp. 1744-1751
• Utreras, E., Maccioni, R., Gonzalez-Billault, C., Cyclin-dependent kinase 5 activator p35 over-expression and amyloid beta synergism increase apoptosis in cultured neuronal cells (2009) Neuroscience, 161, pp. 978-987
• Ubeda, M., Kemp, D.M., Habener, J.F., Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic beta-cells (2004) Endocrinology, 145, pp. 3023-3031
• Mateo, I., Vazquez-Higuera, J.L., Sanchez-Juan, P., Rodriguez-Rodriguez, E., Infante, J., Epistasis between tau phosphorylation regulating genes (CDK5R1 and GSK-3beta) and Alzheimer's disease risk (2008) Acta Neurol Scand
• Moncini, S., Bevilacqua, A., Venturin, M., Fallini, C., Ratti, A., The 39 untranslated region of human Cyclin-Dependent Kinase 5 Regulatory subunit 1 contains regulatory elements affecting transcript stability (2007) BMC Mol Biol, 8, p. 111
• Rademakers, R., Sleegers, K., Theuns, J., Van den Broeck, M., Bel Kacem, S., Association of cyclin-dependent kinase 5 and neuronal activators p35 and p39 complex in early-onset Alzheimer's disease (2005) Neurobiol Aging, 26, pp. 1145-1151
• Lopes, J.P., Oliveira, C.R., Agostinho, P., Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-Beta and prion peptides: Implications for Alzheimer's disease and prion-related encephalopathies (2007) Cell Mol Neurobiol, 27, pp. 943-957
• Monaco III, E.A., Recent evidence regarding a role for Cdk5 dysregulation in Alzheimer's disease (2004) Curr Alzheimer Res, 1, pp. 33-38
• Maccioni, R.B., Otth, C., Concha, I.I., Munoz, J.P., The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology (2001) Eur J Biochem, 268, pp. 1518-1527
• Sato, S., Xu, J., Okuyama, S., Martinez, L.B., Walsh, S.M., Spatial learning impairment, enhanced CDK5/p35 activity, and downregulation of NMDA receptor expression in transgenic mice expressing tau-tubulin kinase 1 (2008) J Neurosci, 28, pp. 14511-14521
• Patrick, G.N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration (1999) Nature, 402, pp. 615-622
• Orellana, D.I., Quintanilla, R.A., Maccioni, R.B., Neuroprotective effect of TNFalpha against the beta-amyloid neurotoxicity mediated by CDK5 kinase (2007) Biochim Biophys Acta, 1773, pp. 254-263
• Ubeda, M., Rukstalis, J.M., Habener, J.F., Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity (2006) J Biol Chem, 281, pp. 28858-28864
• Camins, A., Verdaguer, E., Folch, J., Canudas, A.M., Pallas, M., The role of CDK5/P25 formation/inhibition in neurodegeneration (2006) Drug News Perspect, 19, pp. 453-460
• Quintanilla, R.A., Orellana, D.I., Gonzalez-Billault, C., Maccioni, R.B., Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway (2004) Exp Cell Res, 295, pp. 245-257
• Lee, M.S., Tsai, L.H., Cdk5: One of the links between senile plaques and neurofibrillary tangles? (2003) J Alzheimers Dis, 5, pp. 127-137
• Kesavapany, S., Li, B.S., Pant, H.C., Cyclin-dependent kinase 5 in neurofilament function and regulation (2003) Neurosignals, 12, pp. 252-264
• Mauceri, D., Gardoni, F., Marcello, E., Di Luca, M., Dual role of CaMKIIdependent SAP97 phosphorylation in mediating trafficking and insertion of NMDA receptor subunit NR2A (2007) J Neurochem, 100, pp. 1032-1046
• Surena, A.L., de Faria, G.P., Studler, J.M., Peiretti, F., Pidoux, M., DLG1/SAP97 modulates transforming growth factor alpha bioavailability (2009) Biochim Biophys Acta, 1793, pp. 264-272
• Sato, J., Shimazu, D., Yamamoto, N., Nishikawa, T., An association analysis of synapse-associated protein 97 (SAP97) gene in schizophrenia (2008) J Neural Transm, 115, pp. 1355-1365
• Cai, C., Li, H., Kangasniemi, A., Pihlajamaa, T., Von Ossowski, L., Somatostatin receptor subtype 1 is a PDZ ligand for synapse-associated protein 97 and a potential regulator of growth cone dynamics (2008) Neuroscience, 157, pp. 833-843
• Migues, P.V., Cammarota, M., Kavanagh, J., Atkinson, R., Powis, D.A., Maturational changes in the subunit composition of AMPA receptors and the functional consequences of their activation in chicken forebrain (2007) Dev Neurosci, 29, pp. 232-240
• Cai, C., Li, H., Rivera, C., Keinanen, K., Interaction between SAP97 and PSD-95, two Maguk proteins involved in synaptic trafficking of AMPA receptors (2006) J Biol Chem, 281, pp. 4267-4273
• Nash, J.E., Johnston, T.H., Collingridge, G.L., Garner, C.C., Brotchie, J.M., Subcellular redistribution of the synapse-associated proteins PSD-95 and SAP97 in animal models of Parkinson's disease and L-DOPA-induced dyskinesia (2005) FASEB J, 19, pp. 583-585
• Wakabayashi, K., Narisawa-Saito, M., Iwakura, Y., Arai, T., Ikeda, K., Phenotypic down-regulation of glutamate receptor subunit GluR1 in Alzheimer's disease (1999) Neurobiol Aging, 20, pp. 287-295
• Tavalin, S.J., AKAP79 selectively enhances protein kinase C regulation of GluR1 at a Ca2+-calmodulin-dependent protein kinase II/protein kinase C site (2008) J Biol Chem, 283, pp. 11445-11452
• Gerdjikov, T.V., Rudolph, U., Keist, R., Mohler, H., Feldon, J., Hippocampal alpha 5 subunit-containing GABA A receptors are involved in the development of the latent inhibition effect (2008) Neurobiol Learn Mem, 89, pp. 87-94
• Glykys, J., Mann, E.O., Mody, I., Which GABA(A) receptor subunits are necessary for tonic inhibition in the hippocampus? (2008) J Neurosci, 28, pp. 1421-1426
• Bonin, R.P., Martin, L.J., MacDonald, J.F., Orser, B.A., Alpha5GABAA receptors regulate the intrinsic excitability of mouse hippocampal pyramidal neurons (2007) J Neurophysiol, 98, pp. 2244-2254
• Dawson, G.R., Maubach, K.A., Collinson, N., Cobain, M., Everitt, B.J., An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition (2006) J Pharmacol Exp Ther, 316, pp. 1335-1345
• Caraiscos, V.B., Newell, J.G., You-Ten, K.E., Elliott, E.M., Rosahl, T.W., Selective enhancement of tonic GABAergic inhibition in murine hippocampal neurons by low concentrations of the volatile anesthetic isoflurane (2004) J Neurosci, 24, pp. 8454-8458
• Zarnowska, E.D., Keist, R., Rudolph, U., Pearce, R.A., GABAA receptor alpha5 subunits contribute to GABAA, slow synaptic inhibition in mouse hippocampus (2009) J Neurophysiol, 101, pp. 1179-1191
• Fernandez, F., Esposito, T., Lea, R.A., Colson, N.J., Ciccodicola, A., Investigation of gamma-aminobutyric acid (GABA) A receptors genes and migraine susceptibility (2008) BMC Med Genet, 9, p. 109
• Weiss, J., O'Sullivan, G.A., Heinze, L., Chen, H.X., Betz, H., Glycinergic input of small-field amacrine cells in the retinas of wildtype and glycine receptor deficient mice (2008) Mol Cell Neurosci, 37, pp. 40-55
• Ramanathan, S., Woodroffe, A., Flodman, P.L., Mays, L.Z., Hanouni, M., A case of autism with an interstitial deletion on 4q leading to hemizygosity for genes encoding for glutamine and glycine neurotransmitter receptor sub-units (AMPA 2, GLRA3, GLRB) and neuropeptide receptors NPY1R, NPY5R (2004) BMC Med Genet, 5, p. 10
• Nikolic, Z., Laube, B., Weber, R.G., Lichter, P., Kioschis, P., The human glycine receptor subunit alpha3. Glra3 gene structure, chromosomal localization, and functional characterization of alternative transcripts (1998) J Biol Chem, 273, pp. 19708-19714
• Hunter, R.G., Bellani, R., Bloss, E., Costa, A., McCarthy, K., Regulation of kainate receptor subunit mRNA by stress and corticosteroids in the rat hippocampus (2009) PLoS One, 4, pp. e4328
• Parisiadou, L., Bethani, I., Michaki, V., Krousti, K., Rapti, G., Homer2 and Homer3 interact with amyloid precursor protein and inhibit Abeta production (2008) Neurobiol Dis, 30, pp. 353-364
• Cao, M., Xu, J., Shen, C., Kam, C., Huganir, R.L., PICK1-ICA69 heteromeric BAR domain complex regulates synaptic targeting and surface expression of AMPA receptors (2007) J Neurosci, 27, pp. 12945-12956
• Huang, Z., Shimazu, K., Woo, N.H., Zang, K., Muller, U., Distinct roles of the beta 1-class integrins at the developing and the mature hippocampal excitatory synapse (2006) J Neurosci, 26, pp. 11208-11219
• Thomas, U., Modulation of synaptic signalling complexes by Homer proteins (2002) J Neurochem, 81, pp. 407-413
• Scott, L.J., Muglia, P., Kong, X.Q., Guan, W., Flickinger, M., Genomewide association and meta-analysis of bipolar disorder in individuals of European ancestry (2009) Proc Natl Acad Sci U S A, 106, pp. 7501-7506
• Shin, O.H., Han, W., Wang, Y., Sudhof, T.C., Evolutionarily conserved multiple C2 domain proteins with two transmembrane regions (MCTPs) and unusual Ca2+ binding properties (2005) J Biol Chem, 280, pp. 1641-1651
• Enz, R., Croci, C., Different binding motifs in metabotropic glutamate receptor type 7b for filamin A, protein phosphatase 1C, protein interacting with protein kinase C (PICK) 1 and syntenin allow the formation of multimeric protein complexes (2003) Biochem J, 372, pp. 183-191
• Boczan, J., Leenders, A.G., Sheng, Z.H., Phosphorylation of syntaphilin by cAMP-dependent protein kinase modulates its interaction with syntaxin-1 and annuls its inhibitory effect on vesicle exocytosis (2004) J Biol Chem, 279, pp. 18911-18919
• Kang, J.S., Tian, J.H., Pan, P.Y., Zald, P., Li, C., Docking of axonal mitochondria by syntaphilin controls their mobility and affects short-term facilitation (2008) Cell, 132, pp. 137-148
• Das, S., Gerwin, C., Sheng, Z.H., Syntaphilin binds to dynamin-1 and inhibits dynamin-dependent endocytosis (2003) J Biol Chem, 278, pp. 41221-41226
• Das, S., Boczan, J., Gerwin, C., Zald, P.B., Sheng, Z.H., Regional and developmental regulation of syntaphilin expression in the brain: A candidate molecular element of synaptic functional differentiation (2003) Brain Res Mol Brain Res, 116, pp. 38-49
• Lao, G., Scheuss, V., Gerwin, C.M., Su, Q., Mochida, S., Syntaphilin: A syntaxin-1 clamp that controls SNARE assembly (2000) Neuron, 25, pp. 191-201
• Mahad, D.J., Ziabreva, I., Campbell, G., Lax, N., White, K., Mitochondrial changes within axons in multiple sclerosis (2009) Brain, 132, pp. 1161-1174
• Funakoshi, E., Hamano, A., Fukui, M., Nishiyama, N., Ogita, K., Molecular cloning of the m-Golsyn gene and its expression in the mouse brain (2006) Gene Expr, 13, pp. 27-40
• Funakoshi, E., Nakagawa, K.Y., Hamano, A., Hori, T., Shimizu, A., Molecular cloning and characterization of gene for Golgi-localized syntaphilinrelated protein on human chromosome 8q23 (2005) Gene, 344, pp. 259-271
• Zhou, D., Wang, J., Zapala, M.A., Xue, J., Schork, N.J., Gene expression in mouse brain following chronic hypoxia: Role of sarcospan in glial cell death (2008) Physiol Genomics, 32, pp. 370-379
• Williams, D., Aleman, T., Lillo, C., Lopes, V.S., Hughes, L.C., Harmonin in the murine retina and the retinal phenotypes of Ush1c-mutant mice and human USH1C (2009) Invest Ophthalmol Vis Sci
• Lillo, C., Kitamoto, J., Williams, D.S., Roles and interactions of usher 1 proteins in the outer retina (2006) Adv Exp Med Biol, 572, pp. 341-348
• Reiners, J., Nagel-Wolfrum, K., Jurgens, K., Marker, T., Wolfrum, U., Molecular basis of human Usher syndrome: Deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease (2006) Exp Eye Res, 83, pp. 97-119
• Keri, S., Seres, I., Kelemen, O., Benedek, G., The relationship among neuregulin 1-stimulated phosphorylation of akt, psychosis proneness, and habituation of arousal in nonclinical individuals (2009) Schizophr Bull
• Le Strat, Y., Ramoz, N., Gorwood, P., The role of genes involved in neuroplasticity and neurogenesis in the observation of a gene-environment interaction (GxE) in schizophrenia (2009) Curr Mol Med, 9, pp. 506-518
• Schijndel, J.E., Loo, K.M., Zweeden, M.V., Djurovic, S., Andreassen, O.A., Three-cohort targeted gene screening reveals a non-synonymous TRKA polymorphism associated with schizophrenia (2009) J Psychiatr Res
• So, H.C., Fong, P.Y., Chen, R.Y., Hui, T.C., Ng, M.Y., Identification of neuroglycan C and interacting partners as potential susceptibility genes for schizophrenia in a Southern Chinese population (2009) Am J Med Genet B Neuropsychiatr Genet
• Wood, J.D., Bonath, F., Kumar, S., Ross, C.A., Cunliffe, V.T., Disrupted-inschizophrenia 1 and neuregulin 1 are required for the specification of oligodendrocytes and neurones in the zebrafish brain (2009) Hum Mol Genet, 18, pp. 391-404
• Wong, J., Weickert, C.S., Transcriptional Interaction of an Estrogen Receptor Splice Variant and ErbB4 Suggests Convergence in Gene Susceptibility Pathways in Schizophrenia (2009) J Biol Chem, 284, pp. 18824-18832
• Wang, F., Jiang, T., Sun, Z., Teng, S.L., Luo, X., Neuregulin 1 genetic variation and anterior cingulum integrity in patients with schizophrenia and healthy controls (2009) J Psychiatry Neurosci, 34, pp. 181-186
• Voineskos, D., De Luca, V., Macgregor, S., Likhodi, O., Miller, L., Neuregulin 1 and age of onset in the major psychoses (2009) J Neural Transm, 116, pp. 479-486
• Tabares-Seisdedos, R., Rubenstein, J.L., Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: Implications for schizophrenia, autism and cancer (2009) Mol Psychiatry, 14, pp. 563-589
• Reinhard, S., Vela, E., Bombara, N., Devries, G.H., Raabe, T.D., Developmental regulation of Neuregulin1 isoforms and erbB receptor expression in intact rat dorsal root ganglia (2009) Neurochem Res, 34, pp. 17-22
• Prata, D.P., Breen, G., Osborne, S., Munro, J., St Clair, D., An association study of the neuregulin 1 gene, bipolar affective disorder and psychosis (2009) Psychiatr Genet, 19, pp. 113-116
• Pedrosa, E., Nolan, K.A., Stefanescu, R., Hershcovitz, P., Novak, T., Analysis of a Promoter Polymorphism in the SMDF Neuregulin 1 Isoform in Schizophrenia (2009) Neuropsychobiology, 59, pp. 205-212
• Mata, I., Perez-Iglesias, R., Roiz-Santianez, R., Tordesillas-Gutierrez, D., Gonzalez- Mandly, A., A neuregulin 1 variant is associated with increased lateral ventricle volume in patients with first-episode schizophrenia (2009) Biol Psychiatry, 65, pp. 535-540
• Kircher, T., Thienel, R., Wagner, M., Reske, M., Habel, U., Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas (2009) Eur Arch Psychiatry Clin Neurosci, 259, pp. 72-79
• Kircher, T., Krug, A., Markov, V., Whitney, C., Krach, S., Genetic variation in the schizophrenia-risk gene neuregulin 1 correlates with brain activation and impaired speech production in a verbal fluency task in healthy individuals (2009) Hum Brain Mapp
• Keri, S., Seres, I., Kelemen, O., Benedek, G., Neuregulin 1-stimulated phosphorylation of AKT in psychotic disorders and its relationship with neurocognitive functions (2009) Neurochem Int
• Willem, M., Garratt, A.N., Novak, B., Citron, M., Kaufmann, S., Control of peripheral nerve myelination by the beta-secretase BACE1 (2006) Science, 314, pp. 664-666
• Savonenko, A.V., Melnikova, T., Laird, F.M., Stewart, K.A., Price, D.L., Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenialike phenotypes in BACE1-null mice (2008) Proc Natl Acad Sci U S A, 105, pp. 5585-5590
• Hu, X., He, W., Diaconu, C., Tang, X., Kidd, G.J., Genetic deletion of BACE1 in mice affects remyelination of sciatic nerves (2008) FASEB J, 22, pp. 2970-2980
• Pankonin, M.S., Sohi, J., Kamholz, J., Loeb, J.A., Differential distribution of neuregulin in human brain and spinal fluid (2009) Brain Res, 1258, pp. 1-11
• Li, B., Woo, R.S., Mei, L., Malinow, R., The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity (2007) Neuron, 54, pp. 583-597
• Go, R.C., Perry, R.T., Wiener, H., Bassett, S.S., Blacker, D., Neuregulin-1 polymorphism in late onset Alzheimer's disease families with psychoses (2005) Am J Med Genet B Neuropsychiatr Genet, 139 B, pp. 28-32
• Gallagher, J.P., Orozco-Cabal, L.F., Liu, J., Shinnick-Gallagher, P., Synaptic physiology of central CRH system (2008) Eur J Pharmacol, 583, pp. 215-225
• Liu, Y., Tao, Y.M., Woo, R.S., Xiong, W.C., Mei, L., Stimulated ErbB4 internalization is necessary for neuregulin signaling in neurons (2007) Biochem Biophys Res Commun, 354, pp. 505-510
• MacDonald III, A.W., Chafee, M.V., Translational and developmental perspective on N-methyl-D-aspartate synaptic deficits in schizophrenia (2006) Dev Psychopathol, 18, pp. 853-876
• Jaworski, A., Burden, S.J., Neuromuscular synapse formation in mice lacking motor neuron- and skeletal muscle-derived Neuregulin-1 (2006) J Neurosci, 26, pp. 655-661
• Jacobson, C., Duggan, D., Fischbach, G., Neuregulin induces the expression of transcription factors and myosin heavy chains typical of muscle spindles in cultured human muscle (2004) Proc Natl Acad Sci U S A, 101, pp. 12218-12223
• Okada, M., Corfas, G., Neuregulin1 downregulates postsynaptic GABAA receptors at the hippocampal inhibitory synapse (2004) Hippocampus, 14, pp. 337-344
• Bennett, A.O.M., Dual constraints on synapse formation and regression in schizophrenia: Neuregulin, neuroligin, dysbindin, DISC1, MuSK and agrin (2008) Aust N Z J Psychiatry, 42, pp. 662-677
• Papadopoulos, V., Lecanu, L., Brown, R.C., Han, Z., Yao, Z.X., Peripheraltype benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders (2006) Neuroscience, 138, pp. 749-756
• Hazell, A.S., Astrocytes and manganese neurotoxicity (2002) Neurochem Int, 41, pp. 271-277
• Roberts, J.C., Friel, S.L., Roman, S., Perren, M., Harper, A., Autoradiographical imaging of PPARgamma agonist effects on PBR/TSPO binding in TASTPM mice (2009) Exp Neurol, 216, pp. 459-470
• Ji, B., Maeda, J., Sawada, M., Ono, M., Okauchi, T., Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies (2008) J Neurosci, 28, pp. 12255-12267
• Gulyas, B., Makkai, B., Kasa, P., Gulya, K., Bakota, L., A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR) system (2009) Neurochem Int, 54, pp. 28-36
• Wang, M., Gao, M., Hutchins, G.D., Zheng, Q.H., Synthesis of [11C]FEDAA1106 as a new PET imaging probe of peripheral benzodiazepine receptor expression (2009) Eur J Med Chem, 44, pp. 2748-2753
• Yasuno, F., Ota, M., Kosaka, J., Ito, H., Higuchi, M., Increased binding of peripheral benzodiazepine receptor in Alzheimer's disease measured by positron emission tomography with [11C]DAA1106 (2008) Biol Psychiatry, 64, pp. 835-841
• Laquintana, V., Denora, N., Lopedota, A., Suzuki, H., Sawada, M., Nbenzyl- 2-(6,8-dichloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl)-N-(6-(7- nitrobenzo[c][1,2,5]oxadiazol-4-ylamino)hexyl)acetamide as a new fluorescent probe for peripheral benzodiazepine receptor and microglial cell visualization (2007) Bioconjug Chem, 18, pp. 1397-1407
• Walker, D.G., Dalsing-Hernandez, J.E., Lue, L.F., Human postmortem brainderived cerebrovascular smooth muscle cells express all genes of the classical complement pathway: A potential mechanism for vascular damage in cerebral amyloid angiopathy and Alzheimer's disease (2008) Microvasc Res, 75, pp. 411-419
• Veerhuis, R., Janssen, I., De Groot, C.J., Van Muiswinkel, F.L., Hack, C.E., Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor (1999) Exp Neurol, 160, pp. 289-299
• Yasojima, K., McGeer, E.G., McGeer, P.L., Complement regulators C1 inhibitor and CD59 do not significantly inhibit complement activation in Alzheimer disease (1999) Brain Res, 833, pp. 297-301
• Bergamaschini, L., Canziani, S., Bottasso, B., Cugno, M., Braidotti, P., Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner (1999) Clin Exp Immunol, 115, pp. 526-533
• Yasojima, K., Schwab, C., McGeer, E.G., McGeer, P.L., Up-regulated production and activation of the complement system in Alzheimer's disease brain (1999) Am J Pathol, 154, pp. 927-936
• Terai, K., Walker, D.G., McGeer, E.G., McGeer, P.L., Neurons express proteins of the classical complement pathway in Alzheimer disease (1997) Brain Res, 769, pp. 385-390
• Mori, M., Sawashita, J., Higuchi, K., Functional polymorphisms of the Lss and Fdft1 genes in laboratory rats (2007) Exp Anim, 56, pp. 93-101
• Funfschilling, U., Saher, G., Xiao, L., Mobius, W., Nave, K.A., Survival of adult neurons lacking cholesterol synthesis in vivo (2007) BMC Neurosci, 8, p. 1
• Tang, J., Song, M., Wang, Y., Fan, X., Xu, H., Noggin and BMP4 comodulate adult hippocampal neurogenesis in the APP(swe)/PS1(DeltaE9) transgenic mouse model of Alzheimer's disease (2009) Biochem Biophys Res Commun, 385, pp. 341-345
• Li, D., Tang, J., Xu, H., Fan, X., Bai, Y., Decreased hippocampal cell proliferation correlates with increased expression of BMP4 in the APPswe/ PS1DeltaE9 mouse model of Alzheimer's disease (2008) Hippocampus, 18, pp. 692-698
• Malm, T.M., Magga, J., Kuh, G.F., Vatanen, T., Koistinaho, M., Minocycline reduces engraftment and activation of bone marrow-derived cells but sustains their phagocytic activity in a mouse model of Alzheimer's disease (2008) Glia, 56, pp. 1767-1779
• Kobayashi, K., Hayashi, M., Nakano, H., Fukutani, Y., Sasaki, K., Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes in white matter lesions in Alzheimer's disease (2002) Neuropathol Appl Neurobiol, 28, pp. 238-251
• Fiala, M., Liu, Q.N., Sayre, J., Pop, V., Brahmandam, V., Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier (2002) Eur J Clin Invest, 32, pp. 360-371
• Heneka, M.T., Wiesinger, H., Dumitrescu-Ozimek, L., Riederer, P., Feinstein, D.L., Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease (2001) J Neuropathol Exp Neurol, 60, pp. 906-916
• Kobayashi, K., Muramori, F., Aoki, T., Hayashi, M., Miyazu, K., KP-1 is a marker for extraneuronal neurofibrillary tangles and senile plaques in Alzheimer diseased brains (1998) Dement Geriatr Cogn Disord, 9, pp. 13-19
• Reynolds, W.F., Rhees, J., Maciejewski, D., Paladino, T., Sieburg, H., Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease (1999) Exp Neurol, 155, pp. 31-41
• Damjanac, M., Rioux Bilan, A., Barrier, L., Pontcharraud, R., Anne, C., Fluoro-Jade B staining as useful tool to identify activated microglia and astrocytes in a mouse transgenic model of Alzheimer's disease (2007) Brain Res, 1128, pp. 40-49
• Sim, K.G., Cheong, J.K., Hsu, S.I., The TRIP-Br family of transcriptional regulators is essential for the execution of cyclin E-mediated cell cycle progression (2006) Cell Cycle, 5, pp. 1111-1115
• Cheong, J.K., Gunaratnam, L., Zang, Z.J., Yang, C.M., Sun, X., TRIPBr2 promotes oncogenesis in nude mice and is frequently overexpressed in multiple human tumors (2009) J Transl Med, 7, p. 8
• Zang, Z.J., Sim, K.G., Cheong, J.K., Yang, C.M., Yap, C.S., Exploiting the TRIP-Br family of cell cycle regulatory proteins as chemotherapeutic drug targets in human cancer (2007) Cancer Biol Ther, 6, pp. 712-718
• An, L., Sato, H., Konishi, Y., Walker, D.G., Beach, T.G., Expression and localization of lactotransferrin messenger RNA in the cortex of Alzheimer's disease (2009) Neurosci Lett, 452, pp. 277-280
• Leveugle, B., Spik, G., Perl, D.P., Bouras, C., Fillit, H.M., The ironbinding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: A comparative immunohistochemical analysis (1994) Brain Res, 650, pp. 20-31
• Kawamata, T., Tooyama, I., Yamada, T., Walker, D.G., McGeer, P.L., Lactotransferrin immunocytochemistry in Alzheimer and normal human brain (1993) Am J Pathol, 142, pp. 1574-1585
• Morozova, N., Khrapko, K., Panee, J., Liu, W., Harney, J.W., Glutathione depletion in hippocampal cells increases levels of H and L ferritin and glutathione S-transferase mRNAs (2007) Genes Cells, 12, pp. 561-567
• Connor, J.R., Snyder, B.S., Arosio, P., Loeffler, D.A., LeWitt, P., A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains (1995) J Neurochem, 65, pp. 717-724
• Vidal, R., Miravalle, L., Gao, X., Barbeito, A.G., Baraibar, M.A., Expression of a mutant form of the ferritin light chain gene induces neurodegeneration and iron overload in transgenic mice (2008) J Neurosci, 28, pp. 60-67
• Thomas, M., Jankovic, J., Neurodegenerative disease and iron storage in the brain (2004) Curr Opin Neurol, 17, pp. 437-442
• Wimmer, U., Wang, Y., Georgiev, O., Schaffner, W., Two major branches of anti-cadmium defense in the mouse: MTF-1/metallothioneins and glutathione (2005) Nucleic Acids Res, 33, pp. 5715-5727
• Bellingham, S.A., Coleman, L.A., Masters, C.L., Camakaris, J., Hill, A.F., Regulation of prion gene expression by transcription factors SP1 and metal transcription factor-1 (2009) J Biol Chem, 284, pp. 1291-1301
• Colangelo, V., Schurr, J., Ball, M.J., Pelaez, R.P., Bazan, N.G., Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling (2002) J Neurosci Res, 70, pp. 462-473
• Holloway, A.F., Stennard, F.A., West, A.K., Human metallothionein gene MT1L mRNA is present in several human tissues but is unlikely to produce a metallothionein protein (1997) FEBS Lett, 404, pp. 41-44
• Hahn, Y., Lee, B., Human-specific nonsense mutations identified by genome sequence comparisons (2006) Hum Genet, 119, pp. 169-178
• Choi, K.H., Elashoff, M., Higgs, B.W., Song, J., Kim, S., Putative psychosis genes in the prefrontal cortex: Combined analysis of gene expression microarrays (2008) BMC Psychiatry, 8, p. 87
• Goncalves, I., Quintela, T., Baltazar, G., Almeida, M.R., Saraiva, M.J., Transthyretin interacts with metallothionein 2 (2008) Biochemistry, 47, pp. 2244-2251
• Aschner, M., West, A.K., The role of MT in neurological disorders (2005) J Alzheimers Dis, 8, pp. 139-145. , discussion 209-115
• Richarz, A.N., Bratter, P., Speciation analysis of trace elements in the brains of individuals with Alzheimer's disease with special emphasis on metallothioneins (2002) Anal Bioanal Chem, 372, pp. 412-417
• Irie, Y., Keung, W.M., Metallothionein-III antagonizes the neurotoxic and neurotrophic effects of amyloid beta peptides (2001) Biochem Biophys Res Commun, 282, pp. 416-420
• Kobayashi, K., Hayashi, M., Nakano, H., Shimazaki, M., Sugimori, K., Correlation between astrocyte apoptosis and Alzheimer changes in gray matter lesions in Alzheimer's disease (2004) J Alzheimers Dis, 6, pp. 623-632. , discussion 673-681
• Mattson, M.P., Glutamate and neurotrophic factors in neuronal plasticity and disease (2008) Ann N Y Acad Sci, 1144, pp. 97-112
• Stahelin, R.V., Long, F., Diraviyam, K., Bruzik, K.S., Murray, D., Phosphatidylinositol 3-phosphate induces the membrane penetration of the FYVE domains of Vps27p and Hrs (2002) J Biol Chem, 277, pp. 26379-26388
• Falasca, M., Maffucci, T., Emerging roles of phosphatidylinositol 3- monophosphate as a dynamic lipid second messenger (2006) Arch Physiol Biochem, 112, pp. 274-284
• Sansom, S.N., Griffiths, D.S., Faedo, A., Kleinjan, D.J., Ruan, Y., The level of the transcription factor Pax6 is essential for controlling the balance between neural stem cell self-renewal and neurogenesis (2009) PLoS Genet, 5, pp. e1000511
• von Bohlen Und Halbach, O., Immunohistological markers for staging neurogenesis in adult hippocampus (2007) Cell Tissue Res, 329, pp. 409-420
• Kallur, T., Gisler, R., Lindvall, O., Kokaia, Z., Pax6 promotes neurogenesis in human neural stem cells (2008) Mol Cell Neurosci, 38, pp. 616-628
• Levers, T.E., Edgar, J.M., Price, D.J., The fates of cells generated at the end of neurogenesis in developing mouse cortex (2001) J Neurobiol, 48, pp. 265-277
• Hardy, R.J., QKI expression is regulated during neuron-glial cell fate decisions (1998) J Neurosci Res, 54, pp. 46-57
• Bibel, M., Richter, J., Schrenk, K., Tucker, K.L., Staiger, V., Differentiation of mouse embryonic stem cells into a defined neuronal lineage (2004) Nat Neurosci, 7, pp. 1003-1009
• Baer, K., Eriksson, P.S., Faull, R.L., Rees, M.I., Curtis, M.A., Sox-2 is expressed by glial and progenitor cells and Pax-6 is expressed by neuroblasts in the human subventricular zone (2007) Exp Neurol, 204, pp. 828-831
• Nacher, J., Varea, E., Blasco-Ibanez, J.M., Castillo-Gomez, E., Crespo, C., Expression of the transcription factor Pax 6 in the adult rat dentate gyrus (2005) J Neurosci Res, 81, pp. 753-761
• Malaterre, J., Mantamadiotis, T., Dworkin, S., Lightowler, S., Yang, Q., c-Myb is required for neural progenitor cell proliferation and maintenance of the neural stem cell niche in adult brain (2008) Stem Cells, 26, pp. 173-181
• Lauriat, T.L., Shiue, L., Haroutunian, V., Verbitsky, M., Ares Jr., M., Developmental expression profile of quaking, a candidate gene for schizophrenia, and its target genes in human prefrontal cortex and hippocampus shows regional specificity (2008) J Neurosci Res, 86, pp. 785-796
• Chen, Y., Tian, D., Ku, L., Osterhout, D.J., Feng, Y., The selective RNAbinding protein quaking I (QKI) is necessary and sufficient for promoting oligodendroglia differentiation (2007) J Biol Chem, 282, pp. 23553-23560
• Zhao, L., Ku, L., Chen, Y., Xia, M., LoPresti, P., QKI binds MAP1B mRNA and enhances MAP1B expression during oligodendrocyte development (2006) Mol Biol Cell, 17, pp. 4179-4186
• Aberg, K., Saetre, P., Jareborg, N., Jazin, E., Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia (2006) Proc Natl Acad Sci U S A, 103, pp. 7482-7487
• Galarneau, A., Richard, S., Target RNA motif and target mRNAs of the Quaking STAR protein (2005) Nat Struct Mol Biol, 12, pp. 691-698
• Valjent, E., Aubier, B., Corbille, A.G., Brami-Cherrier, K., Caboche, J., Plasticity-associated gene Krox24/Zif268 is required for long-lasting behavioral effects of cocaine (2006) J Neurosci, 26, pp. 4956-4960
• Nikitin, V.P., Kozyrev, S.A., Effects of antisense oligonucleotides to mRNA for the early gene zif268 on the mechanisms of synapse-specific plasticity (2007) Neurosci Behav Physiol, 37, pp. 607-612
• Poirier, G.L., Amin, E., Aggleton, J.P., Qualitatively different hippocampal subfield engagement emerges with mastery of a spatial memory task by rats (2008) J Neurosci, 28, pp. 1034-1045
• Renaudineau, S., Poucet, B., Laroche, S., Davis, S., Save, E., Impaired longterm stability of CA1 place cell representation in mice lacking the transcription factor zif268/egr1 (2009) Proc Natl Acad Sci U S A, 106, pp. 11771-11775
• Romcy-Pereira, R.N., Erraji-Benchekroun, L., Smyrniotopoulos, P., Ogawa, S., Mello, C.V., Sleep-dependent gene expression in the hippocampus and prefrontal cortex following long-term potentiation (2009) Physiol Behav, 98, pp. 44-52
• Bailey, D.J., Wade, J., Differential expression of the immediate early genes FOS and ZENK following auditory stimulation in the juvenile male and female zebra finch (2003) Brain Res Mol Brain Res, 116, pp. 147-154
• Eda-Fujiwara, H., Satoh, R., Bolhuis, J.J., Kimura, T., Neuronal activation in female budgerigars is localized and related to male song complexity (2003) Eur J Neurosci, 17, pp. 149-154
• Shimizu, T., Bowers, A.N., Budzynski, C.A., Kahn, M.C., Bingman, V.P., What does a pigeon (Columba livia) brain look like during homing? selective examination of ZENK expression (2004) Behav Neurosci, 118, pp. 845-851
• Terpstra, N.J., Bolhuis, J.J., den Boer-Visser, A.M., An analysis of the neural representation of birdsong memory (2004) J Neurosci, 24, pp. 4971-4977
• Bailey, D.J., Wade, J., FOS and ZENK responses in 45-day-old zebra finches vary with auditory stimulus and brain region, but not sex (2005) Behav Brain Res, 162, pp. 108-115
• Terpstra, N.J., Bolhuis, J.J., Den Boer-Visser, A.M., Ten Cate, C., Neuronal activation related to auditory perception in the brain of a non-songbird, the ring dove (2005) J Comp Neurol, 488, pp. 342-351
• Bischofe, H.J., Lieshoff, C., Watanabe, S., Spatial memory and hippocampal function in a non-foodstoring songbird, the zebra finch (Taeniopygia guttata) (2006) Rev Neurosci, 17, pp. 43-52
• Brito, I., Britto, L.R., Ferrari, E.A., Classical tone-shock conditioning induces Zenk expression in the pigeon (Columba livia) hippocampus (2006) Behav Neurosci, 120, pp. 353-361
• Terpstra, N.J., Bolhuis, J.J., Riebel, K., van der Burg, J.M., den Boer-Visser, A.M., Localized brain activation specific to auditory memory in a female songbird (2006) J Comp Neurol, 494, pp. 784-791
• Vignal, C., Bouchut, C., Mathevon, N., Sound-induced brain activity depends on stimulus subjective salience in female zebra finches (2008) C R Biol, 331, pp. 347-356
• Fischer, A.J., McGuire, J.J., Schaeffel, F., Stell, W.K., Light- and focusdependent expression of the transcription factor ZENK in the chick retina (1999) Nat Neurosci, 2, pp. 706-712
• Mello, C.V., Vicario, D.S., Clayton, D.F., Song presentation induces gene expression in the songbird forebrain (1992) Proc Natl Acad Sci U S A, 89, pp. 6818-6822
• Mello, C.V., Clayton, D.F., Song-induced ZENK gene expression in auditory pathways of songbird brain and its relation to the song control system (1994) J Neurosci, 14, pp. 6652-6666
• Mello, C., Nottebohm, F., Clayton, D., Repeated exposure to one song leads to a rapid and persistent decline in an immediate early gene's response to that song in zebra finch telencephalon (1995) J Neurosci, 15, pp. 6919-6925
• Mello, C.V., Clayton, D.F., Differential induction of the ZENK gene in the avian forebrain and song control circuit after metrazole-induced depolarization (1995) J Neurobiol, 26, pp. 145-161
• Mello, C.V., Ribeiro, S., ZENK protein regulation by song in the brain of songbirds (1998) J Comp Neurol, 393, pp. 426-438
• Ribeiro, S., Cecchi, G.A., Magnasco, M.O., Mello, C.V., Toward a song code: Evidence for a syllabic representation in the canary brain (1998) Neuron, 21, pp. 359-371
• Tischmeyer, W., Grimm, R., Activation of immediate early genes and memory formation (1999) Cell Mol Life Sci, 55, pp. 564-574
• Nedivi, E., Hevroni, D., Naot, D., Israeli, D., Citri, Y., Numerous candidate plasticity-related genes revealed by differential cDNA cloning (1993) Nature, 363, pp. 718-722
• Li, L., Yun, S.H., Keblesh, J., Trommer, B.L., Xiong, H., Egr3, a synaptic activity regulated transcription factor that is essential for learning and memory (2007) Mol Cell Neurosci, 35, pp. 76-88
• Soule, J., Penke, Z., Kanhema, T., Alme, M.N., Laroche, S., Object-place recognition learning triggers rapid induction of plasticity-related immediate early genes and synaptic proteins in the rat dentate gyrus (2008) Neural Plast, 2008, p. 269097
• Takahata, T., Higo, N., Kaas, J.H., Yamamori, T., Expression of immediateearly genes reveals functional compartments within ocular dominance columns after brief monocular inactivation (2009) Proc Natl Acad Sci U S A
• Lam, B.Y., Zhang, W., Enticknap, N., Haggis, E., Cader, M.Z., Inverse regulation of plasticity-related immediate early genes by calcineurin in hippocampal neurons (2009) J Biol Chem, 284, pp. 12562-12571
• Pfenning, A.R., Schwartz, R., Barth, A.L., A comparative genomics approach to identifying the plasticity transcriptome (2007) BMC Neurosci, 8, p. 20
• Nikitin, V.P., A new mechanism of synapse-specific neuronal plasticity (2007) Neurosci Behav Physiol, 37, pp. 559-570
• Toscano, C.D., McGlothan, J.L., Guilarte, T.R., Experience-dependent regulation of zif268 gene expression and spatial learning (2006) Exp Neurol, 200, pp. 209-215
• Jenkins, T.A., Amin, E., Brown, M.W., Aggleton, J.P., Changes in immediate early gene expression in the rat brain after unilateral lesions of the hippocampus (2006) Neuroscience, 137, pp. 747-759
• James, A.B., Conway, A.M., Morris, B.J., Regulation of the neuronal proteasome by Zif268 (Egr1) (2006) J Neurosci, 26, pp. 1624-1634
• Ihara, H., Mie, M., Funabashi, H., Takahashi, F., Sawasaki, T., In vitro selection of zinc finger DNA-binding proteins through ribosome display (2006) Biochem Biophys Res Commun, 345, pp. 1149-1154
• Hernandez, P.J., Schiltz, C.A., Kelley, A.E., Dynamic shifts in corticostriatal expression patterns of the immediate early genes Homer 1a and Zif268 during early and late phases of instrumental training (2006) Learn Mem, 13, pp. 599-608
• James, A.B., Conway, A.M., Morris, B.J., Genomic profiling of the neuronal target genes of the plasticity-related transcription factor - Zif268 (2005) J Neurochem, 95, pp. 796-810
• Lee, J.L., Everitt, B.J., Thomas, K.L., Independent cellular processes for hippocampal memory consolidation and reconsolidation (2004) Science, 304, pp. 839-843
• Korzus, E., The relation of transcription to memory formation (2003) Acta Biochim Pol, 50, pp. 775-782
• Davis, S., Bozon, B., Laroche, S., How necessary is the activation of the immediate early gene zif268 in synaptic plasticity and learning? (2003) Behav Brain Res, 142, pp. 17-30
• Blanchard, J., Decorte, L., Nogues, X., Micheau, J., Characterization of cognition alteration across the course of the disease in APP751SL mice with parallel estimation of cerebral Abeta deposition (2009) Behav Brain Res, 201, pp. 147-157
• Blanchard, J., Martel, G., Guillou, J.L., Nogues, X., Micheau, J., Impairment of spatial memory consolidation in APP(751SL) mice results in cue-guided response (2008) Neurobiol Aging, 29, pp. 1011-1021
• Becker, M., Lavie, V., Solomon, B., Stimulation of endogenous neurogenesis by anti-EFRH immunization in a transgenic mouse model of Alzheimer's disease (2007) Proc Natl Acad Sci U S A, 104, pp. 1691-1696
• Dickey, C.A., Loring, J.F., Montgomery, J., Gordon, M.N., Eastman, P.S., Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein+presenilin-1 transgenic mice (2003) J Neurosci, 23, pp. 5219-5226
• Dickey, C.A., Gordon, M.N., Mason, J.E., Wilson, N.J., Diamond, D.M., Amyloid suppresses induction of genes critical for memory consolidation in APP+PS1 transgenic mice (2004) J Neurochem, 88, pp. 434-442
• Kashani, A.H., Qiu, Z., Jurata, L., Lee, S.K., Pfaff, S., Calcium activation of the LMO4 transcription complex and its role in the patterning of thalamocortical connections (2006) J Neurosci, 26, pp. 8398-8408
• Bulchand, S., Subramanian, L., Tole, S., Dynamic spatiotemporal expression of LIM genes and cofactors in the embryonic and postnatal cerebral cortex (2003) Dev Dyn, 226, pp. 460-469
• Azim, E., Shnider, S.J., Cederquist, G.Y., Sohur, U.S., Macklis, J.D., Lmo4 and Clim1 progressively delineate cortical projection neuron subtypes during development (2009) Cereb Cortex, 19 (SUPPL. 1), pp. i62-i69
• Miyajima, N., Maruyama, S., Nonomura, K., Hatakeyama, S., TRIM36 interacts with the kinetochore protein CENP-H and delays cell cycle progression (2009) Biochem Biophys Res Commun, 381, pp. 383-387
• Harrill, J.A., Li, Z., Wright, F.A., Radio, N.M., Mundy, W.R., Transcriptional response of rat frontal cortex following acute in vivo exposure to the pyrethroid insecticides permethrin and deltamethrin (2008) BMC Genomics, 9, p. 546
• Takemoto-Kimura, S., Terai, H., Takamoto, M., Ohmae, S., Kikumura, S., Molecular cloning and characterization of CLICK-III/CaMKIgamma, a novel membrane-anchored neuronal Ca2+/calmodulin-dependent protein kinase (CaMK) (2003) J Biol Chem, 278, pp. 18597-18605
• Takemoto-Kimura, S., Ageta-Ishihara, N., Nonaka, M., Adachi-Morishima, A., Mano, T., Regulation of dendritogenesis via a lipid-raft-associated Ca2+/calmodulin-dependent protein kinase CLICK-III/CaMKIgamma (2007) Neuron, 54, pp. 755-770
• Korostynski, M., Piechota, M., Kaminska, D., Solecki, W., Przewlocki, R., Morphine effects on striatal transcriptome in mice (2007) Genome Biol, 8, pp. R128
• Glorioso, C., Sabatini, M., Unger, T., Hashimoto, T., Monteggia, L.M., Specificity and timing of neocortical transcriptome changes in response to BDNF gene ablation during embryogenesis or adulthood (2006) Mol Psychiatry, 11, pp. 633-648
• Nishimura, H., Sakagami, H., Uezu, A., Fukunaga, K., Watanabe, M., Cloning, characterization and expression of two alternatively splicing isoforms of Ca2+/calmodulin-dependent protein kinase I gamma in the rat brain (2003) J Neurochem, 85, pp. 1216-1227
• Zhao, C., Braunewell, K.H., Expression of the neuronal calcium sensor visinin-like protein-1 in the rat hippocampus (2008) Neuroscience, 153, pp. 1202-1212
• Youn, H., Jeoung, M., Koo, Y., Ji, H., Markesbery, W.R., Kalirin is under-expressed in Alzheimer's disease hippocampus (2007) J Alzheimers Dis, 11, pp. 385-397
• Huang, J.C., Babak, T., Corson, T.W., Chua, G., Khan, S., Using expression profiling data to identify human microRNA targets (2007) Nat Methods, 4, pp. 1045-1049
• Liu, T., Papagiannakopoulos, T., Puskar, K., Qi, S., Santiago, F., Detection of a microRNA signal in an in vivo expression set of mRNAs (2007) PLoS One, 2, pp. e804
• Nikitin, A., Egorov, S., Daraselia, N., Mazo, I., Pathway studio-the analysis and navigation of molecular networks (2003) Bioinformatics, 19, pp. 2155-2157
• Bucan, M., Abrahams, B.S., Wang, K., Glessner, J.T., Herman, E.I., Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes (2009) PLoS Genet, 5, pp. e1000536
• Bourgeron, T., A synaptic trek to autism (2009) Curr Opin Neurobiol
• Glessner, J.T., Wang, K., Cai, G., Korvatska, O., Kim, C.E., Autism genome-wide copy number variation reveals ubiquitin and neuronal genes (2009) Nature, 459, pp. 569-573
• Kumar, R.A., Christian, S.L., Genetics of autism spectrum disorders (2009) Curr Neurol Neurosci Rep, 9, pp. 188-197
• Bourgeron, T., The possible interplay of synaptic and clock genes in autism spectrum disorders (2007) Cold Spring Harb Symp Quant Biol, 72, pp. 645-654
• Marshall, C.R., Noor, A., Vincent, J.B., Lionel, A.C., Feuk, L., Structural variation of chromosomes in autism spectrum disorder (2008) Am J Hum Genet, 82, pp. 477-488
• Kim, H.G., Kishikawa, S., Higgins, A.W., Seong, I.S., Donovan, D.J., Disruption of neurexin 1 associated with autism spectrum disorder (2008) Am J Hum Genet, 82, pp. 199-207
• Owen, M.J., Williams, H.J., O'Donovan, M.C., Schizophrenia genetics: Advancing on two fronts (2009) Curr Opin Genet Dev, 19, pp. 266-270
• Need, A.C., Ge, D., Weale, M.E., Maia, J., Feng, S., A genome-wide investigation of SNPs and CNVs in schizophrenia (2009) PLoS Genet, 5, pp. e1000373
• Rujescu, D., Ingason, A., Cichon, S., Pietilainen, O.P., Barnes, M.R., Disruption of the neurexin 1 gene is associated with schizophrenia (2009) Hum Mol Genet, 18, pp. 988-996
• Vrijenhoek, T., Buizer-Voskamp, J.E., van der Stelt, I., Strengman, E., Sabatti, C., Recurrent CNVs disrupt three candidate genes in schizophrenia patients (2008) Am J Hum Genet, 83, pp. 504-510
• Kirov, G., Gumus, D., Chen, W., Norton, N., Georgieva, L., Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia (2008) Hum Mol Genet, 17, pp. 458-465
• Nussbaum, J., Xu, Q., Payne, T.J., Ma, J.Z., Huang, W., Significant association of the neurexin-1 gene (NRXN1) with nicotine dependence in European- and African-American smokers (2008) Hum Mol Genet, 17, pp. 1569-1577
• Bierut, L.J., Madden, P.A., Breslau, N., Johnson, E.O., Hatsukami, D., Novel genes identified in a high-density genome wide association study for nicotine dependence (2007) Hum Mol Genet, 16, pp. 24-35
• Yang, H.C., Chang, C.C., Lin, C.Y., Chen, C.L., Fann, C.S., A genome-wide scanning and fine mapping study of COGA data (2005) BMC Genet, 6 (SUPPL. 1), pp. S30
• Zahir, F.R., Baross, A., Delaney, A.D., Eydoux, P., Fernandes, N.D., A patient with vertebral, cognitive and behavioural abnormalities and a de novo deletion of NRXN1alpha (2008) J Med Genet, 45, pp. 239-243
• Cabodi, S., Morello, V., Masi, A., Cicchi, R., Broggio, C., Convergence of integrins and EGF receptor signaling via PI3K/Akt/FoxO pathway in early gene Egr-1 expression (2009) J Cell Physiol, 218, pp. 294-303
• Nowak, K., Killmer, K., Gessner, C., Lutz, W., E2F-1 regulates expression of FOXO1 and FOXO3a (2007) Biochim Biophys Acta, 1769, pp. 244-252
• Yuan, Z., Lehtinen, M.K., Merlo, P., Villen, J., Gygi, S., Regulation of neuronal cell death by MST1-FOXO1 signaling (2009) J Biol Chem, 284, pp. 11285-11292
• Yuan, Z., Becker, E.B., Merlo, P., Yamada, T., DiBacco, S., Activation of FOXO1 by Cdk1 in cycling cells and postmitotic neurons (2008) Science, 319, pp. 1665-1668
• Kim, A.H., Bonni, A., Cdk1-FOXO1: A mitotic signal takes center stage in post-mitotic neurons (2008) Cell Cycle, 7, pp. 3819-3822
• van der Heide, L.P., Ramakers, G.M., Smidt, M.P., Insulin signaling in the central nervous system: Learning to survive (2006) Prog Neurobiol, 79, pp. 205-221
• Horwood, J.M., Dufour, F., Laroche, S., Davis, S., Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat (2006) Eur J Neurosci, 23, pp. 3375-3384
• Polter, A., Yang, S., Zmijewska, A.A., van Groen, T., Paik, J.H., Forkhead box, class O transcription factors in brain: Regulation and behavioral manifestation (2009) Biol Psychiatry, 65, pp. 150-159
• Wu, H., Lu, D., Jiang, H., Xiong, Y., Qu, C., Increase in phosphorylation of Akt and its downstream signaling targets and suppression of apoptosis by simvastatin after traumatic brain injury (2008) J Neurosurg, 109, pp. 691-698
• Sasaki, T., Han, F., Shioda, N., Moriguchi, S., Kasahara, J., Lithiuminduced activation of Akt and CaM kinase II contributes to its neuroprotective action in a rat microsphere embolism model (2006) Brain Res, 1108, pp. 98-106
• Hoekman, M.F., Jacobs, F.M., Smidt, M.P., Burbach, J.P., Spatial and temporal expression of FoxO transcription factors in the developing and adult murine brain (2006) Gene Expr Patterns, 6, pp. 134-140
• Samarin, J., Cicha, I., Goppelt-Struebe, M., Cell type-specific regulation of CCN2 protein expression by PI3K-AKT-FoxO signaling (2009) J Cell Commun Signal, 3, pp. 79-84
• Fukuda, M., Jones, J.E., Olson, D., Hill, J., Lee, C.E., Monitoring FoxO1 localization in chemically identified neurons (2008) J Neurosci, 28, pp. 13640-13648
• Tajes, M., Yeste-Velasco, M., Zhu, X., Chou, S.P., Smith, M.A., Activation of Akt by lithium: Pro-survival pathways in aging (2009) Mech Ageing Dev, 130, pp. 253-261
• Chiang, C.W., Yan, L., Yang, E., Phosphatases and regulation of cell death (2008) Methods Enzymol, 446, pp. 237-257
• Lukiw, W.J., Pogue, A.I., Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells (2007) J Inorg Biochem, 101, pp. 1265-1269
• Alafuzoff, I., Arzberger, T., Al-Sarraj, S., Bodi, I., Bogdanovic, N., Staging of neurofibrillary pathology in Alzheimer's disease: A study of the BrainNet Europe Consortium (2008) Brain Pathol, 18, pp. 484-496
• Marzolo, M.P., Bu, G., Lipoprotein receptors and cholesterol in APP trafficking and proteolytic processing, implications for Alzheimer's disease (2009) Semin Cell Dev Biol, 20, pp. 191-200
• Jaeger, S., Pietrzik, C.U., Functional role of lipoprotein receptors in Alzheimer's disease (2008) Curr Alzheimer Res, 5, pp. 15-25
• Cam, J.A., Bu, G., Modulation of beta-amyloid precursor protein trafficking and processing by the low density lipoprotein receptor family (2006) Mol Neurodegener, 1, p. 8
• Bu, G., Cam, J., Zerbinatti, C., LRP in amyloid-beta production and metabolism (2006) Ann N Y Acad Sci, 1086, pp. 35-53
• Carter, C.J., Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis (2007) Neurochem Int, 50, pp. 12-38
• Cam, J.A., Zerbinatti, C.V., Knisely, J.M., Hecimovic, S., Li, Y., The low density lipoprotein receptor-related protein 1B retains beta-amyloid precursor protein at the cell surface and reduces amyloid-beta peptide production (2004) J Biol Chem, 279, pp. 29639-29646
• Duilio, A., Faraonio, R., Minopoli, G., Zambrano, N., Russo, T., Fe65L2: A new member of the Fe65 protein family interacting with the intracellular domain of the Alzheimer's beta-amyloid precursor protein (1998) Biochem J, 330 (PT 1), pp. 513-519
• Tanahashi, H., Tabira, T., Genome structure and chromosomal mapping of the gene for Fe65L2 interacting with Alzheimer's beta-amyloid precursor protein (1999) Biochem Biophys Res Commun, 258, pp. 385-389
• Tanahashi, H., Tabira, T., Molecular cloning of human Fe65L2 and its interaction with the Alzheimer's beta-amyloid precursor protein (1999) Neurosci Lett, 261, pp. 143-146
• Tanahashi, H., Asada, T., Tabira, T., C954CRT polymorphism in the Fe65L2 gene is associated with early-onset Alzheimer's disease (2002) Ann Neurol, 52, pp. 691-693
• Tamayev, R., Zhou, D., D'Adamio, L., The interactome of the amyloid beta precursor protein family members is shaped by phosphorylation of their intracellular domains (2009) Mol Neurodegener, 4, p. 28
• Zhou, D., Zambrano, N., Russo, T., D'Adamio, L., Phosphorylation of a tyrosine in the amyloid-beta protein precursor intracellular domain inhibits Fe65 binding and signaling (2009) J Alzheimers Dis, 16, pp. 301-307
• McLoughlin, D.M., Miller, C.C., The FE65 proteins and Alzheimer's disease (2008) J Neurosci Res, 86, pp. 744-754
• Chang, Y., Tesco, G., Jeong, W.J., Lindsley, L., Eckman, E.A., Generation of the beta-amyloid peptide and the amyloid precursor protein Cterminal fragment gamma are potentiated by FE65L1 (2003) J Biol Chem, 278, pp. 51100-51107
• Poduslo, S.E., Huang, R., Spiro III, A., A genome screen of successful aging without cognitive decline identifies LRP1B by haplotype analysis (2010) Am J Med Genet B Neuropsychiatr Geneti, 153 B
• McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease (1984) Neurology, 34, p. 939
• Folstein, M.F., Folstein, S.E., McHugh, P.R., "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician (1975) Journal of Psychiatric Research, 12, pp. 189-198
• Rosen, W., Mohs, R., Davis, K., A new rating scale for Alzheimer's disease (1984) Am J Psychiatry, 141, pp. 1356-1364
• Schmitt, F.A., Wetherby, M.M.C., Wekstein, D.R., Dearth, C.M.S., Markesbery, W.R., Brain Donation in Normal Aging: Procedures, Motivations, and Donor Characteristics From the Biologically Resilient Adults in Neurological Studies (BRAiNS) Project (2001) Gerontologist, 41, pp. 716-722
• Geddes, J.W., Tekirian, T.L., Soultanian, N.S., Ashford, J.W., Davis, D.G., Comparison of neuropathologic criteria for the diagnosis of Alzheimer's disease (1997) Neurobiol Aging, 18, pp. S99-S105
• Braak, H., Braak, E., Neuropathological stageing of Alzheimer-related changes (1991) Acta Neuropathol, 82, pp. 239-259
• Bancher, C., Braak, H., Fischer, P., Jellinger, K.A., Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients (1993) Neurosci Lett, 162, pp. 179-182
• Braak, H., Braak, E., Staging of Alzheimer's disease-related neurofibrillary changes (1995) Neurobiol Aging, 16, pp. 271-278. , discussion 278-284
• (1993) Multi-Interval Discretization of Continuous-Valued Attributes for Classification Learning Morgan Kaufmann, pp. 1022-1029. , Fayyad UM, Irani KB, eds
• Berretta, R., Mendes, A., Moscato, P., Selection of Discriminative Genes in Microarray Experiments Using Mathematical Programming (2007) Journal of Research and Practice in Information Technology, 39, pp. 287-299
• Cotta, C., Sloper, C., Moscato, P., Evolutionary search of thresholds for robust feature set selection: Application to the analysis of microarray data (2004) Applications of Evolutionary Computing Springer, pp. 21-30. , In: Raidl GR, Cagnoni S, Branke J, Corne DW, Drechsler R, et al. eds., Berlin/Heidelberg
• Gómez Ravetti, M., Berretta, R., Moscato, P., Novel Biomarkers for Prostate Cancer Revealed by (α,β)-k-Feature Sets (2009) Foundations of Computational Intelligence, 5, pp. 149-175
• Hourani, M., Berretta, R., Mendes, A., Moscato, P., Genetic signatures for a rodent model of Parkinson's disease using combinatorial optimization methods (2008) Methods Mol Biol, 453, pp. 379-392
• Mendes, A., Scott, R.J., Moscato, P., Microarrays-identifying molecular portraits for prostate tumors with different Gleason patterns (2008) Methods Mol Med, 141, pp. 131-151
• Rosso, O.A., Mendes, A., Berretta, R., Rostas, J.A., Hunter, M., Distinguishing childhood absence epilepsy patients from controls by the analysis of their background brain electrical activity (II): A combinatorial optimization approach for electrode selection (2009) J Neurosci Methods, 181, pp. 257-267
• Cotta, C., Langston, M.A., Moscato, P., Combinatorial and algorithmic issues for microarray analysis (2007) Handbook of Approximation Algorithms and Metaheuristics, pp. 74.71-74.14. , In: Gonzalez TF, ed., Chapman & Hall/CRC
• Chang, J.T., Nevins, J.R., GATHER: A systems approach to interpreting genomic signatures (2006) Bioinformatics, 22, pp. 2926-2933
• Blalock, E.M., Geddes, J.W., Chen, K.C., Porter, N.M., Markesbery, W.R., Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses (2004) Proc Natl Acad Sci U S A, 101, pp. 2173-2178
• Zhao, C.J., Noack, C., Brackmann, M., Gloveli, T., Maelicke, A., Neuronal Ca2+ sensor VILIP-1 leads to the upregulation of functional alpha4beta2 nicotinic acetylcholine receptors in hippocampal neurons (2009) Mol Cell Neurosci, 40, pp. 280-292
• Bernstein, H.G., Braunewell, K.H., Some notes on visinin-like protein 1 and Alzheimer disease (2009) Clin Chem, 55, pp. 1041-1043
• Lee, J.M., Blennow, K., Andreasen, N., Laterza, O., Modur, V., The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients (2008) Clin Chem, 54, pp. 1617-1623
• Zhao, C., Anand, R., Braunewell, K.H., Nicotine-induced Ca2+-myristoyl switch of neuronal Ca2+ sensor VILIP-1 in hippocampal neurons: A possible crosstalk mechanism for nicotinic receptors (2009) Cell Mol Neurobiol, 29, pp. 273-286
• Gierke, P., Zhao, C., Bernstein, H.G., Noack, C., Anand, R., Implication of neuronal Ca2+ -sensor protein VILIP-1 in the glutamate hypothesis of schizophrenia (2008) Neurobiol Dis, 32, pp. 162-175
• Schnurra, I., Bernstein, H.G., Riederer, P., Braunewell, K.H., The neuronal calcium sensor protein VILIP-1 is associated with amyloid plaques and extracellular tangles in Alzheimer's disease and promotes cell death and tau phosphorylation in vitro: A link between calcium sensors and Alzheimer's disease? (2001) Neurobiol Dis, 8, pp. 900-909
• Braunewell, K., Riederer, P., Spilker, C., Gundelfinger, E.D., Bogerts, B., Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (vilips)-1 and -3, in neocortical brain areas of Alzheimer disease patients (2001) Dement Geriatr Cogn Disord, 12, pp. 110-116
• Killick, R., Scales, G., Leroy, K., Causevic, M., Hooper, C., Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice (2009) Biochem Biophys Res Commun, 386, pp. 257-262
• Bulbarelli, A., Lonati, E., Cazzaniga, E., Gregori, M., Masserini, M., Pin1 affects Tau phosphorylation in response to Abeta oligomers (2009) Mol Cell Neurosci, 42, pp. 75-80
• Zhao, W.Q., Feng, C., Alkon, D.L., Impairment of phosphatase 2A contributes to the prolonged MAP kinase phosphorylation in Alzheimer's disease fibroblasts (2003) Neurobiol Dis, 14, pp. 458-469
• Vafai, S.B., Stock, J.B., Protein phosphatase 2A methylation: A link between elevated plasma homocysteine and Alzheimer's Disease (2002) FEBS Lett, 518, pp. 1-4
• Wei, Q., Holzer, M., Brueckner, M.K., Liu, Y., Arendt, T., Dephosphorylation of tau protein by calcineurin triturated into neural living cells (2002) Cell Mol Neurobiol, 22, pp. 13-24
• Tian, Q., Wang, J., Role of serine/threonine protein phosphatase in Alzheimer's disease (2002) Neurosignals, 11, pp. 262-269
• Gong, C.X., Wang, J.Z., Iqbal, K., Grundke-Iqbal, I., Inhibition of protein phosphatase 2A induces phosphorylation and accumulation of neurofilaments in metabolically active rat brain slices (2003) Neurosci Lett, 340, pp. 107-110
• Munch, G., Kuhla, B., Luth, H.J., Arendt, T., Robinson, S.R., Anti-AGEing defences against Alzheimer's disease (2003) Biochem Soc Trans, 31, pp. 1397-1399
• Sontag, E., Luangpirom, A., Hladik, C., Mudrak, I., Ogris, E., Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology (2004) J Neuropathol Exp Neurol, 63, pp. 287-301
• Rametti, A., Esclaire, F., Yardin, C., Terro, F., Linking alterations in tau phosphorylation and cleavage during neuronal apoptosis (2004) J Biol Chem, 279, pp. 54518-54528
• Iqbal, K., Liu, F., Gong, C.X., Alonso Adel, C., Grundke-Iqbal, I., Mechanisms of tau-induced neurodegeneration (2009) Acta Neuropathol, 118, pp. 53-69
• Deters, N., Ittner, L.M., Gotz, J., Substrate-specific reduction of PP2A activity exaggerates tau pathology (2009) Biochem Biophys Res Commun, 379, pp. 400-405
• Liang, Z., Liu, F., Iqbal, K., Grundke-Iqbal, I., Wegiel, J., Decrease of protein phosphatase 2A and its association with accumulation and hyperphosphorylation of tau in Down syndrome (2008) J Alzheimers Dis, 13, pp. 295-302
• Chen, S., Li, B., Grundke-Iqbal, I., Iqbal, K., I1PP2A affects tau phosphorylation via association with the catalytic subunit of protein phosphatase 2A (2008) J Biol Chem, 283, pp. 10513-10521
• Liu, R., Zhou, X.W., Tanila, H., Bjorkdahl, C., Wang, J.Z., Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology (2008) J Cell Mol Med, 12, pp. 241-257
• Meske, V., Albert, F., Ohm, T.G., Coupling of mammalian target of rapamycin with phosphoinositide 3-kinase signaling pathway regulates protein phosphatase 2A- and glycogen synthase kinase-3 -dependent phosphorylation of Tau (2008) J Biol Chem, 283, pp. 100-109
• Walton, J.R., An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration (2007) J Inorg Biochem, 101, pp. 1275-1284
• Nowotny, P., Bertelsen, S., Hinrichs, A.L., Kauwe, J.S., Mayo, K., Association studies between common variants in prolyl isomerase Pin1 and the risk for late-onset Alzheimer's disease (2007) Neurosci Lett, 419, pp. 15-17
• Chohan, M.O., Khatoon, S., Iqbal, I.G., Iqbal, K., Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine (2006) FEBS Lett, 580, pp. 3973-3979
• Plattner, F., Angelo, M., Giese, K.P., The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation (2006) J Biol Chem, 281, pp. 25457-25465
• Kerr, F., Rickle, A., Nayeem, N., Brandner, S., Cowburn, R.F., PTEN, a negative regulator of PI3 kinase signalling, alters tau phosphorylation in cells by mechanisms independent of GSK-3 (2006) FEBS Lett, 580, pp. 3121-3128
• Liu, F., Grundke-Iqbal, I., Iqbal, K., Gong, C.X., Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation (2005) Eur J Neurosci, 22, pp. 1942-1950
• Madeira, A., Pommet, J.M., Prochiantz, A., Allinquant, B., SET protein (TAF1beta, I2PP2A) is involved in neuronal apoptosis induced by an amyloid precursor protein cytoplasmic subdomain (2005) FASEB J, 19, pp. 1905-1907
• Snyder, E.M., Nong, Y., Almeida, C.G., Paul, S., Moran, T., Regulation of NMDA receptor trafficking by amyloid-beta (2005) Nat Neurosci, 8, pp. 1051-1058
• Rahman, A., Grundke-Iqbal, I., Iqbal, K., PP2B isolated from human brain preferentially dephosphorylates Ser-262 and Ser-396 of the Alzheimer disease abnormally hyperphosphorylated tau (2006) J Neural Transm, 113, pp. 219-230
• Rahman, A., Grundke-Iqbal, I., Iqbal, K., Phosphothreonine-212 of Alzheimer abnormally hyperphosphorylated tau is a preferred substrate of protein phosphatase-1 (2005) Neurochem Res, 30, pp. 277-287
• Cheng, L.Y., Wang, J.Z., Gong, C.X., Pei, J.J., Zaidi, T., Multiple forms of phosphatase from human brain: Isolation and partial characterization of affi-gel blue binding phosphatases (2000) Neurochem Res, 25, pp. 107-120
• Garver, T.D., Lehman, R.A., Billingsley, M.L., Microtubule assembly competence analysis of freshly-biopsied human tau, dephosphorylated tau, and Alzheimer tau (1996) J Neurosci Res, 44, pp. 12-20
• Matsuo, E.S., Shin, R.W., Billingsley, M.L., Van deVoorde, A., O'Connor, M., Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau (1994) Neuron, 13, pp. 989-1002
• Bajo, M., Yoo, B.C., Cairns, N., Gratzer, M., Lubec, G., Neurofilament proteins NF-L, NF-M and NF-H in brain of patients with Down syndrome and Alzheimer's disease (2001) Amino Acids, 21, pp. 293-301
• Blass, J.P., Markesbery, W.R., Ko, L.W., DeGiorgio, L., Sheu, K.F., Presence of neuronal proteins in serially cultured cells from autopsy human brain (1994) J Neurol Sci, 121, pp. 132-138
• Cairns, N.J., Uryu, K., Bigio, E.H., Mackenzie, I.R., Gearing, M., Alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases (2004) Acta Neuropathol, 108, pp. 213-223
• DeGiorgio, L.A., Sheu, K.F., Blass, J.P., Culture from human leptomeninges of cells containing neurofilament protein and neuron-specific enolase (1994) J Neurol Sci, 124, pp. 141-148
• Deng, Y., Li, B., Liu, F., Iqbal, K., Grundke-Iqbal, I., Regulation between O-GlcNAcylation and phosphorylation of neurofilament-M and their dysregulation in Alzheimer disease (2008) Faseb J, 22, pp. 138-145
• Faigon, M., Hadas, E., Alroy, G., Chapman, J., Auerbach, J.M., Monoclonal antibodies to the heavy neurofilament subunit (NF-H) of Torpedo cholinergic neurons (1991) J Neurosci Res, 29, pp. 490-498
• Hollosi, M., Holly, S., Majer, Z., Laczko, I., Fasman, G.D., Complexes of aluminium with peptide ligands: A Fourier transform IR spectroscopic study (1995) Biopolymers, 36, pp. 381-389
• Hollosi, M., Shen, Z.M., Perczel, A., Fasman, G.D., Stable intrachain and interchain complexes of neurofilament peptides: A putative link between Al3+ and Alzheimer disease (1994) Proc Natl Acad Sci U S A, 91, pp. 4902-4906
• Hollosi, M., Urge, L., Perczel, A., Kajtar, J., Teplan, I., Metal ioninduced conformational changes of phosphorylated fragments of human neurofilament (NF-M) protein (1992) J Mol Biol, 223, pp. 673-682
• Holly, S., Laczko, I., Fasman, G.D., Hollosi, M., FT-IR spectroscopy indicates that Ca(2+)-binding to phosphorylated C-terminal fragments of the midsized neurofilament protein subunit results in beta-sheet formation and betaaggregation (1993) Biochem Biophys Res Commun, 197, pp. 755-762
• Hu, Y.Y., He, S.S., Wang, X.C., Duan, Q.H., Khatoon, S., Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients (2002) Neurosci Lett, 320, pp. 156-160
• Julien, J.P., Mushynski, W.E., Neurofilaments in health and disease (1998) Prog Nucleic Acid Res Mol Biol, 61, pp. 1-23
• Kittur, S., Hoh, J., Endo, H., Tourtellotte, W., Weeks, B.S., Cytoskeletal neurofilament gene expression in brain tissue from Alzheimer's disease patients. I. Decrease in NF-L and NF-M message (1994) J Geriatr Psychiatry Neurol, 7, pp. 153-158
• Ksiezak-Reding, H., Yen, S.H., Two monoclonal antibodies recognize Alzheimer's neurofibrillary tangles, neurofilament, and microtubule-associated proteins (1987) J Neurochem, 48, pp. 455-462
• Lee, V.M., Otvos Jr., L., Carden, M.J., Hollosi, M., Dietzschold, B., Identification of the major multiphosphorylation site in mammalian neurofilaments (1988) Proc Natl Acad Sci U S A, 85, pp. 1998-2002
• Li, S.P., Deng, Y.Q., Wang, X.C., Wang, Y.P., Wang, J.Z., Melatonin protects SH-SY5Y neuroblastoma cells from calyculin A-induced neurofilament impairment and neurotoxicity (2004) J Pineal Res, 36, pp. 186-191
• Miller, C.C., Brion, J.P., Calvert, R., Chin, T.K., Eagles, P.A., Alzheimer's paired helical filaments share epitopes with neurofilament side arms (1986) Embo J, 5, pp. 269-276
• Pollak, D., Cairns, N., Lubec, G., Cytoskeleton derangement in brain of patients with Down syndrome, Alzheimer's disease and Pick's disease (2003) J Neural Transm, (SUPPL.), pp. 149-158
• Roder, H.M., Ingram, V.M., Two novel kinases phosphorylate tau and the KSP site of heavy neurofilament subunits in high stoichiometric ratios (1991) J Neurosci, 11, pp. 3325-3343
• Save, M.P., Shetty, V.P., Shetty, K.T., Antia, N.H., Alterations in neurofilament protein(s) in human leprous nerves: Morphology, immunohistochemistry and Western immunoblot correlative study (2004) Neuropathol Appl Neurobiol, 30, pp. 635-650
• Schmidt, M.L., Lee, V.M., Trojanowski, J.Q., Analysis of epitopes shared by Hirano bodies and neurofilament proteins in normal and Alzheimer's disease hippocampus (1989) Lab Invest, 60, pp. 513-522
• Schmidt, M.L., Lee, V.M., Trojanowski, J.Q., Comparative epitope analysis of neuronal cytoskeletal proteins in Alzheimer's disease senile plaque neurites and neuropil threads (1991) Lab Invest, 64, pp. 352-357
• Shen, Z.M., Perczel, A., Hollosi, M., Nagypal, I., Fasman, G.D., Study of Al3+ binding and conformational properties of the alanine-substituted C-terminal domain of the NF-M protein and its relevance to Alzheimer's disease (1994) Biochemistry, 33, pp. 9627-9636
• Trojanowski, J.Q., Schmidt, M.L., Otvos Jr., L., Gur, R.C., Gur, R.E., Selective expression of epitopes in multiphosphorylation repeats of the high and middle molecular weight neurofilament proteins in Alzheimer neurofibrillary tangles (1989) Ann Med, 21, pp. 113-116
• Troy, C.M., Greene, L.A., Shelanski, M.L., Neurite outgrowth in peripherindepleted PC12 cells (1992) J Cell Biol, 117, pp. 1085-1092
• Wang, J., Tung, Y.C., Wang, Y., Li, X.T., Iqbal, K., Hyperphosphorylation and accumulation of neurofilament proteins in Alzheimer disease brain and in okadaic acid-treated SY5Y cells (2001) FEBS Lett, 507, pp. 81-87
• Wang, Y., Wang, Q., Wang, J., Detection of level and mutation of neurofilament mRNA in Alzheimer's disease (2002) Zhonghua Yi Xue Za Zhi, 82, pp. 519-522
• Wang, Y.P., Wei, Z.L., Wang, X.C., Wang, Q., Wang, J.Z., Comparative study of the expression and phosphorylation of neurofilament proteins of brain gray matter in Alzheimer's disease (2001) Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 23, pp. 445-449
• Wurtman, R.J., Ulus, I.H., Cansev, M., Watkins, C.J., Wang, L., Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally (2006) Brain Res, 1088, pp. 83-92
• Yang, X., Yang, Y., Luo, Y., Li, G., Wang, J., Hyperphosphorylation and Accumulation of Neurofilament Proteins in Transgenic Mice with Alzheimer Presenilin 1 Mutation (2009) Cell Mol Neurobiol
• Yao, P.J., Coleman, P.D., Reduced O-glycosylated clathrin assembly protein AP180: Implication for synaptic vesicle recycling dysfunction in Alzheimer's disease (1998) Neurosci Lett, 252, pp. 33-36
• Laterza, O.F., Modur, V.R., Crimmins, D.L., Olander, J.V., Landt, Y., Identification of novel brain biomarkers (2006) Clin Chem, 52, pp. 1713-1721
• Zhao, C., Anand, R., Braunewell, K.H., Nicotine-induced Ca(2+)-myristoyl Switch of Neuronal Ca(2+) Sensor VILIP-1 in Hippocampal Neurons: A Possible Crosstalk Mechanism for Nicotinic Receptors (2008) Cell Mol Neurobiol
• Zhao, C., Noack, C., Brackmann, M., Gloveli, T., Maelicke, A., Neuronal Ca(2+) sensor VILIP-1 leads to the upregulation of functional alpha4beta2 nicotinic acetylcholine receptors in hippocampal neurons (2008) Mol Cell Neurosci
• Briand, C., Kozlov, S.V., Sonderegger, P., Grutter, M.G., Crystal structure of neuroserpin: A neuronal serpin involved in a conformational disease (2001) FEBS Lett, 505, pp. 18-22
• Bruno, M.A., Cuello, A.C., Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade (2006) Proc Natl Acad Sci U S A, 103, pp. 6735-6740
• Carrell, R.W., Cell toxicity and conformational disease (2005) Trends Cell Biol, 15, pp. 574-580
• Crowther, D.C., Familial conformational diseases and dementias (2002) Hum Mutat, 20, pp. 1-14
• Dufour, A., Corsini, E., Gelati, M., Massa, G., Tarcic, N., Mutations in the neuroserpin gene are rare in familial dementia. French Alzheimer's Disease and Fronto-Temporal Dementia Genetics Study Groups (2000) Ann Neurol, 47, p. 688
• Kinghorn, K.J., Crowther, D.C., Sharp, L.K., Nerelius, C., Davis, R.L., Neuroserpin binds Abeta and is a neuroprotective component of amyloid plaques in Alzheimer disease (2006) J Biol Chem, 281, pp. 29268-29277
• Nielsen, H.M., Minthon, L., Londos, E., Blennow, K., Miranda, E., Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies (2007) Neurology, 69, pp. 1569-1579
• Tabira, T., Familial non-Alzheimer dementia (2003) Rinsho Shinkeigaku, 43, pp. 775-778
• Yamasaki, M., Li, W., Johnson, D.J., Huntington, J.A., Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization (2008) Nature, 455, pp. 1255-1258
• Opii, W.O., Joshi, G., Head, E., Milgram, N.W., Muggenburg, B.A., Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: Relevance to Alzheimer's disease (2008) Neurobiol Aging, 29, pp. 51-70
• Poon, H.F., Farr, S.A., Thongboonkerd, V., Lynn, B.C., Banks, W.A., Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: Implications for aging and age-related neurodegenerative disorders (2005) Neurochem Int, 46, pp. 159-168
• Somerville, M.J., Percy, M.E., Bergeron, C., Yoong, L.K., Grima, E.A., Localization and quantitation of 68 kDa neurofilament and superoxide dismutase-1 mRNA in Alzheimer brains (1991) Brain Res Mol Brain Res, 9, pp. 1-8
• Wishart, T.M., Paterson, J.M., Short, D.M., Meredith, S., Robertson, K.A., Differential proteomics analysis of synaptic proteins identifies potential cellular targets and protein mediators of synaptic neuroprotection conferred by the slow Wallerian degeneration (Wlds) gene (2007) Mol Cell Proteomics, 6, pp. 1318-1330
• Shen, Y., Halperin, J.A., Lee, C.M., Complement-mediated neurotoxicity is regulated by homologous restriction (1995) Brain Res, 671, pp. 282-292
• Wallace, M.A., Effects of Alzheimer's disease-related beta amyloid protein fragments on enzymes metabolizing phosphoinositides in brain (1994) Biochim Biophys Acta, 1227, pp. 183-187
• Shimohama, S., Matsushima, H., Signal transduction mechanisms in Alzheimer disease (1995) Alzheimer Dis Assoc Disord, 9 (SUPPL. 2), pp. 15-22
• Sambamurti, K., Sevlever, D., Koothan, T., Refolo, L.M., Pinnix, I., Glycosylphosphatidylinositol-anchored proteins play an important role in the biogenesis of the Alzheimer's amyloid beta-protein (1999) J Biol Chem, 274, pp. 26810-26814
• Strosznajder, J.B., Zambrzycka, A., Kacprzak, M.D., Strosznajder, R.P., Amyloid beta peptide 25-35 modulates hydrolysis of phosphoinositides by membrane phospholipase(s) C of adult brain cortex (1999) J Mol Neurosci, 12, pp. 101-109
• Zambrzycka, A., Cakala, M., Kaminska, M., Transition metal ions significantly decrease phospholipase C activity degrading phosphatidylinositol- 4,5-bisphosphate in the brain cortex (2003) Pol J Pharmacol, 55, pp. 915-917
• Merlos-Suarez, A., Ruiz-Paz, S., Baselga, J., Arribas, J., Metalloproteasedependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme (2001) J Biol Chem, 276, pp. 48510-48517
• Gilmore, G.C., Wenk, H.E., Naylor, L.A., Koss, E., Motion perception and Alzheimer's disease (1994) J Gerontol, 49, pp. P52-P57
• Hayes, T.L., Lewis, D.A., Nonphosphorylated neurofilament protein and calbindin immunoreactivity in layer III pyramidal neurons of human neocortex (1992) Cereb Cortex, 2, pp. 56-67
• Chin, J., Palop, J.J., Puolivali, J., Massaro, C., Bien-Ly, N., Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease (2005) J Neurosci, 25, pp. 9694-9703
• Falangola, M.F., Dyakin, V.V., Lee, S.P., Bogart, A., Babb, J.S., Quantitative MRI reveals aging-associated T2 changes in mouse models of Alzheimer's disease (2007) NMR Biomed, 20, pp. 343-351
• Helpern, J.A., Lee, S.P., Falangola, M.F., Dyakin, V.V., Bogart, A., MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease (2004) Magn Reson Med, 51, pp. 794-798
• Lahiri, D.K., Chen, D., Ge, Y.W., Farlow, M., Kotwal, G., Does nitric oxide synthase contribute to the pathogenesis of Alzheimer's disease?: Effects of beta-amyloid deposition on NOS in transgenic mouse brain with AD pathology (2003) Ann N Y Acad Sci, 1010, pp. 639-642
• Levine, S., Saltzman, A., Levy, E., Ginsberg, S.D., Systemic pathology in aged mouse models of Down's syndrome and Alzheimer's disease (2009) Exp Mol Pathol, 86, pp. 18-22
• Neiva, T.J., Fries, D.M., Monteiro, H.P., D'Amico, E.A., Chamone, D.A., Aluminum induces lipid peroxidation and aggregation of human blood platelets (1997) Braz J Med Biol Res, 30, pp. 599-604
• Parent, A., Linden, D.J., Sisodia, S.S., Borchelt, D.R., Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FADlinked presenilin 1 (1999) Neurobiol Dis, 6, pp. 56-62
• Perez, S.E., Lumayag, S., Kovacs, B., Mufson, E.J., Xu, S., Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease (2009) Invest Ophthalmol Vis Sci, 50, pp. 793-800
• Sadowski, M., Pankiewicz, J., Scholtzova, H., Ji, Y., Quartermain, D., Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice (2004) J Neuropathol Exp Neurol, 63, pp. 418-428
• Sahara, N., Vega, I.E., Ishizawa, T., Lewis, J., McGowan, E., Phosphorylated p38MAPK specific antibodies cross-react with sarkosylinsoluble hyperphosphorylated tau proteins (2004) J Neurochem, 90, pp. 829-838
• Wang, C.Y., Shen, Y.C., Lo, F.Y., Su, C.H., Lee, S.H., Normal tension glaucoma is not associated with the interleukin -1alpha (-889) genetic polymorphism (2007) J Glaucoma, 16, pp. 230-233
• Wang, C.Y., Shen, Y.C., Su, C.H., Lo, F.Y., Lee, S.H., Investigation of the association between interleukin-1beta polymorphism and normal tension glaucoma (2007) Mol Vis, 13, pp. 719-723
• Wang, X., Su, B., Siedlak, S.L., Moreira, P.I., Fujioka, H., Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins (2008) Proc Natl Acad Sci U S A, 105, pp. 19318-19323
• Yu, W.H., Matsuoka, Y., Sziraki, I., Hashim, A., Lafrancois, J., Increased dopaminergic neuron sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in transgenic mice expressing mutant A53T alpha-synuclein (2008) Neurochem Res, 33, pp. 902-911
• Zhuo, J.M., Prakasam, A., Murray, M.E., Zhang, H.Y., Baxter, M.G., An increase in Abeta42 in the prefrontal cortex is associated with a reversallearning impairment in Alzheimer's disease model Tg2576 APPsw mice (2008) Curr Alzheimer Res, 5, pp. 385-391
• Freude, S., Plum, L., Schnitker, J., Leeser, U., Udelhoven, M., Peripheral hyperinsulinemia promotes tau phosphorylation in vivo (2005) Diabetes, 54, pp. 3343-3348
• Lowe, X.R., Lu, X., Marchetti, F., Wyrobek, A.J., The expression of Troponin T1 gene is induced by ketamine in adult mouse brain (2007) Brain Res, 1174, pp. 7-17
• Morris, B.J., A forkhead in the road to longevity: The molecular basis of lifespan becomes clearer (2005) J Hypertens, 23, pp. 1285-1309
• Nakagawa, K., Kitazume, S., Oka, R., Maruyama, K., Saido, T.C., Sialylation enhances the secretion of neurotoxic amyloid-beta peptides (2006) J Neurochem, 96, pp. 924-933
• Lian, Q., Ladner, C.J., Magnuson, D., Lee, J.M., Selective changes of calcineurin (protein phosphatase 2B) activity in Alzheimer's disease cerebral cortex (2001) Exp Neurol, 167, pp. 158-165
• Shibata, N., Kobayashi, M., The role for oxidative stress in neurodegenerative diseases (2008) Brain Nerve, 60, pp. 157-170
• Wang, H., Dong, K., Li, G., Peng, X., Zhu, H., Effect of yizhi jiannao granules on the expression of Pin1 and HMGB1 mRNA in the hippocampus of SAMP8 mice (2009) Zhong Nan Da Xue Xue Bao Yi Xue Ban, 34, pp. 63-66
• Yang, G., Wang, L., Zhu, M., Xu, D., Identification of non-Alzheimer's disease tauopathies-related proteins by proteomic analysis (2008) Neurol Res, 30, pp. 613-622
• Desjardins, P., Ledoux, S., Expression of ced-3 and ced-9 homologs in Alzheimer's disease cerebral cortex (1998) Neurosci Lett, 244, pp. 69-72
• Akiyama, H., Nishimura, T., Kondo, H., Ikeda, K., Hayashi, Y., Expression of the receptor for macrophage colony stimulating factor by brain microglia and its upregulation in brains of patients with Alzheimer's disease and amyotrophic lateral sclerosis (1994) Brain Res, 639, pp. 171-174
• Boissonneault, V., Filali, M., Lessard, M., Relton, J., Wong, G., Powerful beneficial effects of macrophage colony-stimulating factor on {beta}-amyloid deposition and cognitive impairment in Alzheimer's disease (2009) Brain
• Du Yan, S., Zhu, H., Fu, J., Yan, S.F., Roher, A., Amyloid-beta peptidereceptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory pathway in Alzheimer disease (1997) Proc Natl Acad Sci U S A, 94, pp. 5296-5301
• Ebadi, M., Bashir, R.M., Heidrick, M.L., Hamada, F.M., Refaey, H.E., Neurotrophins and their receptors in nerve injury and repair (1997) Neurochem Int, 30, pp. 347-374
• Flanagan, A.M., Lader, C.S., Update on the biologic effects of macrophage colony-stimulating factor (1998) Curr Opin Hematol, 5, pp. 181-185
• Georganopoulou, D.G., Chang, L., Nam, J.M., Thaxton, C.S., Mufson, E.J., Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease (2005) Proc Natl Acad Sci U S A, 102, pp. 2273-2276
• Hamilton, J.A., Whitty, G., White, A.R., Jobling, M.F., Thompson, A., Alzheimer's disease amyloid beta and prion protein amyloidogenic peptides promote macrophage survival, DNA synthesis and enhanced proliferative response to CSF-1 (M-CSF) (2002) Brain Res, 940, pp. 49-54
• Hasegawa, Y., Sawada, M., Ozaki, N., Inagaki, T., Suzumura, A., Increased soluble tumor necrosis factor receptor levels in the serum of elderly people (2000) Gerontology, 46, pp. 185-188
• Ito, S., Sawada, M., Haneda, M., Fujii, S., Oh-Hashi, K., Amyloid-beta peptides induce cell proliferation and macrophage colony-stimulating factor expression via the PI3-kinase/Akt pathway in cultured Ra2 microglial cells (2005) FEBS Lett, 579, pp. 1995-2000
• Kaku, M., Tsutsui, K., Motokawa, M., Kawata, T., Fujita, T., Amyloid beta protein deposition and neuron loss in osteopetrotic (op/op) mice (2003) Brain Res Brain Res Protoc, 12, pp. 104-108
• Kawata, T., Tsutsui, K., Kohno, S., Kaku, M., Fujita, T., Amyloid beta protein deposition in osteopetrotic (op/op) mice is reduced by injections of macrophage colony stimulating factor (2005) J Int Med Res, 33, pp. 654-660
• Kondo, Y., Lemere, C.A., Seabrook, T.J., Osteopetrotic (op/op) mice have reduced microglia, no Abeta deposition, and no changes in dopaminergic neurons (2007) J Neuroinflammation, 4, p. 31
• Kong, Q.L., Zhang, J.M., Zhang, Z.X., Ge, P.J., Xu, Y.J., Serum levels of macrophage colony stimulating factor in the patients with Alzheimer's disease (2002) Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 24, pp. 298-301
• Kumar, A.P., Piedrafita, F.J., Reynolds, W.F., Peroxisome proliferatoractivated receptor gamma ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism (2004) J Biol Chem, 279, pp. 8300-8315
• Lee, S.C., Liu, W., Brosnan, C.F., Dickson, D.W., GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures (1994) Glia, 12, pp. 309-318
• Li, M., Pisalyaput, K., Galvan, M., Tenner, A.J., Macrophage colony stimulatory factor and interferon-gamma trigger distinct mechanisms for augmentation of beta-amyloid-induced microglia-mediated neurotoxicity (2004) J Neurochem, 91, pp. 623-633
• Lue, L.F., Rydel, R., Brigham, E.F., Yang, L.B., Hampel, H., Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro (2001) Glia, 35, pp. 72-79
• Lue, L.F., Walker, D.G., Brachova, L., Beach, T.G., Rogers, J., Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: Identification of a cellular activation mechanism (2001) Exp Neurol, 171, pp. 29-45
• Lue, L.F., Walker, D.G., Rogers, J., Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures (2001) Neurobiol Aging, 22, pp. 945-956
• Majumdar, A., Cruz, D., Asamoah, N., Buxbaum, A., Sohar, I., Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils (2007) Mol Biol Cell, 18, pp. 1490-1496
• Mitrasinovic, O.M., Grattan, A., Robinson, C.C., Lapustea, N.B., Poon, C., Microglia overexpressing the macrophage colony-stimulating factor receptor are neuroprotective in a microglial-hippocampal organotypic coculture system (2005) J Neurosci, 25, pp. 4442-4451
• Mitrasinovic, O.M., Murphy Jr., G.M., Microglial overexpression of the MCSF receptor augments phagocytosis of opsonized Abeta (2003) Neurobiol Aging, 24, pp. 807-815
• Mitrasinovic, O.M., Perez, G.V., Zhao, F., Lee, Y.L., Poon, C., Overexpression of macrophage colony-stimulating factor receptor on microglial cells induces an inflammatory response (2001) J Biol Chem, 276, pp. 30142-30149
• Mitrasinovic, O.M., Robinson, C.C., Tenen, D.G., Lee, Y.L., Poon, C., Biolistic expression of the macrophage colony stimulating factor receptor in organotypic cultures induces an inflammatory response (2004) J Neurosci Res, 77, pp. 420-429
• Mitrasinovic, O.M., Vincent, V.A., Simsek, D., Murphy Jr., G.M., Macrophage colony stimulating factor promotes phagocytosis by murine microglia (2003) Neurosci Lett, 344, pp. 185-188
• Murphy Jr., G.M., Zhao, F., Yang, L., Cordell, B., Expression of macrophage colony-stimulating factor receptor is increased in the AbetaPP(V717F) transgenic mouse model of Alzheimer's disease (2000) Am J Pathol, 157, pp. 895-904
• Vincent, V.A., Robinson, C.C., Simsek, D., Murphy, G.M., Macrophage colony stimulating factor prevents NMDA-induced neuronal death in hippocampal organotypic cultures (2002) J Neurochem, 82, pp. 1388-1397
• Vincent, V.A., Selwood, S.P., Murphy Jr., G.M., Proinflammatory effects of M-CSF and A beta in hippocampal organotypic cultures (2002) Neurobiol Aging, 23, pp. 349-362
• Wollmer, M.A., Nitsch, R.M., Hock, C., Papassotiropoulos, A., Genetic association study on colony-stimulating factor 1 in Alzheimer's disease (2006) Neurodegener Dis, 3, pp. 334-337
• Yan, S.D., Stern, D., Kane, M.D., Kuo, Y.M., Lampert, H.C., RAGEAbeta interactions in the pathophysiology of Alzheimer's disease (1998) Restor Neurol Neurosci, 12, pp. 167-173
• Zhang, J.M., Kong, Q.L., Wang, H., Qin, C., He, W., Expression of macrophage colony stimulating factor in brains of PDAPPV717I transgenic mice (2004) Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 26, pp. 62-65
• Marsagishvili, L.G., Shpagina, M.D., Emel'ianenko, V.I., Podlubnaia, Z.A., Sarcomeric proteins of the titin family form amyloids (2005) Biofizika, 50, pp. 803-809

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------